CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | eugenol |
|
Accession: | CHEBI:4917
|
browse the term
|
Definition: | A phenylpropanoid formally derived from guaiacol with an allyl chain substituted para to the hydroxy group. It is a major component of clove essential oil, and exhibits antibacterial, analgesic and antioxidant properties. It has been widely used in dentistry to treat toothache and pulpitis. |
Synonyms: | related_synonym: | 1,3,4-Eugenol; 1-Hydroxy-2-methoxy-4-allylbenzene; 1-Hydroxy-2-methoxy-4-prop-2-enylbenzene; 1-Hydroxy-2-methoxy-4-propenylbenzene; 1-allyl-3-methoxy-4-hydroxybenzene; 1-allyl-4-hydroxy-3-methoxybenzene; 2-Hydroxy-5-allylanisole; 2-Methoxy-4-(2-propen-1-yl)phenol; 2-Methoxy-4-(2-propenyl)phenol; 2-Methoxy-4-(prop-2-en-1-yl)phenol; 2-Methoxy-4-allylphenol; 2-Methoxy-4-prop-2-enylphenol; 2-methoxy-4-prop-2-enyl-phenol; 4-Allyl-1-hydroxy-2-methoxybenzene; 4-Allyl-2-methoxyphenol; 4-Allylcatechol-2-methyl ether; 4-Allylguaiacol; 4-Hydroxy-3-methoxy-1-allylbenzene; Allylguaiacol; Caryophyllic acid; Eugenic acid; Formula=C10H12O2; InChI=1S/C10H12O2/c1-3-4-8-5-6-9(11)10(7-8)12-2/h3,5-7,11H,1,4H2,2H3; InChIKey=RRAFCDWBNXTKKO-UHFFFAOYSA-N; SMILES=COC1=CC(CC=C)=CC=C1O; p-Allylguaiacol; p-Eugenol |
| xref: | BPDB:2008; CAS:97-53-0; Chemspider:13876103; Drug_Central:4648; FooDB:FDB012171; HMDB:HMDB0005809; KEGG:C10453; KEGG:D04117; KNApSAcK:C00000619; LINCS:LSM-2720 |
| xref_mesh: | MESH:D005054 |
| xref: | MetaCyc:CPD-6481; PDBeChem:EOL; PMID:11033063; PMID:11806158; PMID:14745850; PMID:15574415; PMID:18218839; PMID:20809147; PMID:22075131; PMID:22923067; PMID:23181601; PMID:23261812; PMID:23264268; PMID:2329164; PMID:23313798; PMID:23325490; PMID:23422484; PMID:23422489; PMID:23444040; PMID:23594212; PMID:23666640; PMID:23677922; PMID:23707945; PMID:23768603; PMID:23768604; PMID:23791894; PMID:23837051; PMID:23841789; PMID:23852671; PMID:28044068; PMID:29079364; PMID:32737935; PMID:33291666; PMID:33916044; PMID:8596779; PMID:9084914; Reaxys:1366759; Wikipedia:Eugenol |
|
|
|
G |
Abca6 |
ATP binding cassette subfamily A member 6 |
decreases expression |
ISO |
Eugenol results in decreased expression of ABCA6 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr10:95,142,805...95,212,087
Ensembl chr10:95,142,966...95,211,530
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions |
EXP |
Eugenol inhibits the reaction [Chlorpyrifos results in decreased expression of ACHE protein] |
CTD |
PMID:32096903 |
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions increases activity affects localization |
ISO |
[Eugenol co-treated with acetyleugenol] inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; [Eugenol co-treated with acetyleugenol] results in increased activity of AHR protein; Eugenol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein]; Eugenol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein] Eugenol results in increased activity of AHR protein Eugenol affects the localization of AHR protein |
CTD |
PMID:17275817 PMID:22686307 PMID:29191726 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Ahrr |
aryl-hydrocarbon receptor repressor |
increases expression |
ISO |
Eugenol results in increased expression of AHRR mRNA |
CTD |
PMID:22686307 |
|
NCBI chr 1:28,993,634...29,088,673
Ensembl chr 1:28,993,634...29,088,673
|
|
G |
Akr1b1 |
aldo-keto reductase family 1 member B1 |
increases expression |
ISO |
Eugenol results in increased expression of AKR1B1 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
increases expression |
ISO |
Eugenol results in increased expression of AKR1B10 mRNA |
CTD |
PMID:20566472 PMID:26198647 PMID:30806763 |
|
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
|
|
G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
increases expression |
ISO |
Eugenol results in increased expression of AKR1C1 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
increases expression |
ISO |
Eugenol results in increased expression of AKR1C2 mRNA |
CTD |
PMID:26198647 |
|
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
increases expression |
ISO |
Eugenol results in increased expression of AKR1C3 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
|
|
G |
Alb |
albumin |
multiple interactions |
EXP |
Eugenol inhibits the reaction [Streptozocin results in decreased expression of ALB protein] |
CTD |
PMID:38047382 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
increases expression |
ISO |
Eugenol results in increased expression of ALPL mRNA |
CTD |
PMID:22083529 |
|
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
multiple interactions |
ISO |
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of APAF1 protein] |
CTD |
PMID:20434464 |
|
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
Eugenol binds to and results in decreased activity of AR protein |
CTD |
PMID:20226658 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Arhgap17 |
Rho GTPase activating protein 17 |
decreases expression |
ISO |
Eugenol results in decreased expression of ARHGAP17 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 1:177,807,579...177,897,027
Ensembl chr 1:177,807,583...177,896,854
|
|
G |
Arl4c |
ARF like GTPase 4C |
increases expression |
ISO |
Eugenol results in increased expression of ARL4C mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 9:89,300,335...89,303,770
Ensembl chr 9:89,298,005...89,304,513
|
|
G |
Atf3 |
activating transcription factor 3 |
increases expression |
ISO |
Eugenol results in increased expression of ATF3 mRNA |
CTD |
PMID:23999411 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
B2m |
beta-2 microglobulin |
increases expression |
ISO |
Eugenol results in increased expression of B2M mRNA |
CTD |
PMID:17936526 |
|
NCBI chr 3:109,095,740...109,101,764
Ensembl chr 3:109,095,729...109,101,766
|
|
G |
Bad |
BCL2-associated agonist of cell death |
multiple interactions |
ISO |
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of BAD mRNA] |
CTD |
PMID:20434464 |
|
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression |
ISO |
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of BAX mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of BAX protein] Eugenol results in increased expression of BAX mRNA |
CTD |
PMID:20434464 PMID:20537511 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression |
ISO |
[Eugenol results in increased activity of sulforaphane] which results in decreased expression of BCL2; [sulforaphane results in increased activity of Eugenol] which results in decreased expression of BCL2 Eugenol inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of BCL2 mRNA]; Eugenol inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of BCL2 protein]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BCL2 mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BCL2 protein] Eugenol results in decreased expression of BCL2 mRNA |
CTD |
PMID:20434464 PMID:20537511 PMID:21382956 PMID:21939359 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
multiple interactions |
ISO |
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BCL2L1 mRNA] |
CTD |
PMID:20434464 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G |
Bclaf1 |
BCL2-associated transcription factor 1 |
decreases expression |
ISO |
Eugenol results in decreased expression of BCLAF1 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 1:15,088,436...15,117,666
Ensembl chr 1:15,070,894...15,148,832
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
increases expression |
ISO |
Eugenol results in increased expression of BDNF mRNA |
CTD |
PMID:15157811 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Bid |
BH3 interacting domain death agonist |
multiple interactions |
ISO |
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of BID mRNA] |
CTD |
PMID:20434464 |
|
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Bmp6 |
bone morphogenetic protein 6 |
increases expression |
ISO |
Eugenol results in increased expression of BMP6 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr17:26,318,121...26,469,691
Ensembl chr17:26,318,569...26,470,365
|
|
G |
Bub1 |
BUB1 mitotic checkpoint serine/threonine kinase |
decreases expression |
ISO |
Eugenol results in decreased expression of BUB1 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 3:115,020,254...115,051,650
Ensembl chr 3:115,020,254...115,051,650
|
|
G |
Calcrl |
calcitonin receptor like receptor |
increases expression |
ISO |
Eugenol results in increased expression of CALCRL mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 3:69,428,348...69,525,910
Ensembl chr 3:69,430,120...69,525,910
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases expression increases activity increases cleavage |
ISO EXP |
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CASP3 mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CASP3 protein] Eugenol results in increased expression of CASP3 mRNA Eugenol results in increased activity of CASP3 protein Eugenol inhibits the reaction [Chlorpyrifos results in increased expression of CASP3 protein]; Eugenol inhibits the reaction [Doxorubicin results in increased expression of CASP3 protein] Eugenol results in increased expression of CASP3 protein modified form Eugenol results in increased cleavage of CASP3 protein |
CTD |
PMID:20434464 PMID:20537511 PMID:21656368 PMID:25455450 PMID:30518369 PMID:32096903 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp7 |
caspase 7 |
increases expression |
ISO |
Eugenol results in increased expression of CASP7 mRNA |
CTD |
PMID:30518369 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases expression increases activity |
ISO |
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CASP9 protein] Eugenol results in increased expression of CASP9 mRNA Eugenol results in increased activity of CASP9 protein |
CTD |
PMID:20434464 PMID:25455450 PMID:30518369 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
increases expression decreases activity multiple interactions |
ISO EXP |
Eugenol results in increased expression of CAT mRNA Eugenol results in decreased activity of CAT protein Eugenol inhibits the reaction [Acetic Acid results in increased activity of CAT protein]; Eugenol inhibits the reaction [Chlorpyrifos results in decreased expression of CAT protein] CAT protein inhibits the reaction [[CYP2D6 protein co-treated with Copper] results in increased activity of Eugenol] |
CTD |
PMID:15576237 PMID:20566472 PMID:32096903 PMID:33245926 PMID:36007673 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl12 |
C-C motif chemokine ligand 12 |
increases expression |
ISO |
Eugenol results in increased expression of CCL13 mRNA |
CTD |
PMID:17936526 |
|
NCBI chr10:67,070,230...67,071,780
Ensembl chr10:67,070,230...67,071,780
|
|
G |
Ccl19 |
C-C motif chemokine ligand 19 |
increases expression |
ISO |
Eugenol results in increased expression of CCL19 mRNA |
CTD |
PMID:17936526 |
|
NCBI chr 5:56,963,364...56,965,308
Ensembl chr 5:56,963,364...56,965,308
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
increases expression increases secretion decreases expression |
ISO |
Eugenol results in increased expression of CCL2 mRNA Eugenol results in increased secretion of CCL2 protein Eugenol results in decreased expression of CCL2 mRNA |
CTD |
PMID:15585374 PMID:17374397 PMID:17936526 PMID:22245253 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
increases expression |
ISO |
Eugenol results in increased expression of CCL20 mRNA |
CTD |
PMID:30806763 |
|
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
increases expression increases secretion |
ISO |
Eugenol results in increased expression of CCL3 mRNA Eugenol results in increased secretion of CCL3 protein |
CTD |
PMID:15585374 PMID:23624239 |
|
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
increases expression increases secretion |
ISO |
Eugenol results in increased expression of CCL4 mRNA; Eugenol results in increased expression of CCL4 protein Eugenol results in increased secretion of CCL4 protein |
CTD |
PMID:15585374 PMID:18353026 PMID:30806763 |
|
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
|
|
G |
Ccnb1 |
cyclin B1 |
multiple interactions |
EXP |
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CCNB1 mRNA] |
CTD |
PMID:19851710 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions |
EXP |
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CCND1 mRNA] |
CTD |
PMID:19851710 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
decreases expression |
ISO |
Eugenol results in decreased expression of CCR2 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
increases expression |
ISO |
Eugenol results in increased expression of CCR5 mRNA |
CTD |
PMID:17936526 PMID:20713136 |
|
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
|
|
G |
Ccr7 |
C-C motif chemokine receptor 7 |
increases expression |
ISO |
Eugenol results in increased expression of CCR7 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr10:84,098,193...84,108,309
Ensembl chr10:84,097,381...84,108,309
|
|
G |
Cd24 |
CD24 molecule |
decreases expression |
ISO |
Eugenol results in decreased expression of CD24 protein |
CTD |
PMID:31926151 |
|
NCBI chr20:47,074,353...47,079,662
Ensembl chr20:47,073,512...47,079,662
|
|
G |
Cd274 |
CD274 molecule |
increases expression |
ISO |
Eugenol results in increased expression of CD274 protein |
CTD |
PMID:23624239 |
|
NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
|
|
G |
Cd36 |
CD36 molecule |
decreases expression |
ISO |
Eugenol results in decreased expression of CD36 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
|
|
G |
Cd44 |
CD44 molecule |
decreases expression |
ISO |
Eugenol results in decreased expression of CD44 protein |
CTD |
PMID:31926151 |
|
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
|
|
G |
Cd86 |
CD86 molecule |
multiple interactions increases expression |
ISO |
[Dicumarol results in decreased activity of NQO1 protein] inhibits the reaction [Eugenol results in increased expression of CD86 protein] |
CTD |
PMID:12423654 PMID:20488241 PMID:21742781 PMID:23624239 PMID:30806763 |
|
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
|
|
G |
Cdk6 |
cyclin-dependent kinase 6 |
decreases expression |
ISO |
Eugenol results in decreased expression of CDK6 protein |
CTD |
PMID:22686307 |
|
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions |
ISO EXP |
Eugenol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDKN1A protein] Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CDKN1A protein] |
CTD |
PMID:19851710 PMID:20043298 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
increases expression |
ISO |
Eugenol results in increased expression of CDKN1B protein |
CTD |
PMID:22686307 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cish |
cytokine inducible SH2-containing protein |
decreases expression |
ISO |
Eugenol results in decreased expression of CISH mRNA |
CTD |
PMID:15618236 |
|
NCBI chr 8:107,972,306...107,977,254
Ensembl chr 8:107,972,306...107,977,250
|
|
G |
Clec4a3 |
C-type lectin domain family 4, member A3 |
decreases expression |
ISO |
Eugenol results in decreased expression of CLEC4A protein |
CTD |
PMID:23624239 |
|
NCBI chr 4:156,214,030...156,224,818
Ensembl chr 4:156,214,718...156,224,817
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
affects expression |
ISO |
Eugenol affects the expression of CREB1 mRNA |
CTD |
PMID:20385217 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Crem |
cAMP responsive element modulator |
increases expression |
ISO |
Eugenol results in increased expression of CREM mRNA |
CTD |
PMID:17374397 |
|
NCBI chr17:54,238,889...54,305,989
Ensembl chr17:54,239,030...54,305,989
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions decreases expression |
ISO |
Eugenol results in decreased expression of and affects the phosphorylation of and affects the localization of CTNNB1 protein Eugenol results in decreased expression of CTNNB1 mRNA |
CTD |
PMID:31926151 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Ctsl |
cathepsin L |
increases expression |
ISO |
Eugenol results in increased expression of CTSL mRNA |
CTD |
PMID:17374397 |
|
NCBI chr17:764,370...770,533
Ensembl chr17:764,309...770,548
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
increases expression |
ISO |
Eugenol results in increased expression of CXCL1 mRNA |
CTD |
PMID:20713136 |
|
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
increases expression multiple interactions |
ISO |
Eugenol results in increased expression of CXCL1 mRNA Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL1 mRNA] |
CTD |
PMID:12963494 PMID:20713136 |
|
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
increases expression |
ISO |
Eugenol results in increased expression of CXCR4 mRNA |
CTD |
PMID:20713136 |
|
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions |
ISO |
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CYCS mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CYCS protein] |
CTD |
PMID:20434464 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions increases expression decreases expression decreases activity |
ISO |
[CYP1A1 protein co-treated with Copper] results in increased activity of Eugenol; Eugenol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; Eugenol inhibits the reaction [CYP1A1 protein results in increased metabolism of and results in increased activity of 9,10-Dimethyl-1,2-benzanthracene]; Eugenol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] Eugenol results in increased expression of CYP1A1 mRNA Eugenol results in decreased expression of CYP1A1 mRNA Eugenol results in decreased activity of CYP1A1 protein |
CTD |
PMID:15576237 PMID:17275817 PMID:20713136 PMID:22686307 PMID:29191726 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
[CYP1A2 protein co-treated with Copper] results in increased activity of Eugenol |
CTD |
PMID:15576237 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
multiple interactions decreases activity |
ISO |
Eugenol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; Eugenol inhibits the reaction [CYP1B1 protein results in increased metabolism of and results in increased activity of 9,10-Dimethyl-1,2-benzanthracene] Eugenol results in decreased activity of CYP1B1 protein |
CTD |
PMID:17275817 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp27a1 |
cytochrome P450, family 27, subfamily a, polypeptide 1 |
decreases expression |
ISO |
Eugenol results in decreased expression of CYP27A1 mRNA |
CTD |
PMID:20713136 |
|
NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
multiple interactions increases metabolic processing |
ISO |
[CYP2D6 protein co-treated with Copper] results in increased activity of Eugenol; [CYP2D6 protein results in increased metabolism of Eugenol] which results in increased abundance of 2-hydroxychavicol; [Eugenol co-treated with Copper co-treated with CYP2D6 protein] results in increased abundance of 8-Hydroxy-2'-Deoxyguanosine; bathocuproine inhibits the reaction [[CYP2D6 protein co-treated with Copper] results in increased activity of Eugenol]; CAT protein inhibits the reaction [[CYP2D6 protein co-treated with Copper] results in increased activity of Eugenol]; methional inhibits the reaction [[CYP2D6 protein co-treated with Copper] results in increased activity of Eugenol] |
CTD |
PMID:15576237 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions |
EXP ISO |
Eugenol inhibits the reaction [Thioacetamide results in increased expression of CYP2E1 protein] [CYP2E1 protein co-treated with Copper] results in increased activity of Eugenol |
CTD |
PMID:15576237 PMID:20036707 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Dkc1 |
dyskerin pseudouridine synthase 1 |
decreases expression |
ISO |
Eugenol results in decreased expression of DKC1 mRNA |
CTD |
PMID:17374397 |
|
|
|
G |
Dlgap5 |
DLG associated protein 5 |
decreases expression |
ISO |
Eugenol results in decreased expression of DLGAP5 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr15:20,633,964...20,664,569
Ensembl chr15:20,633,966...20,664,518
|
|
G |
Dnajb4 |
DnaJ heat shock protein family (Hsp40) member B4 |
increases expression |
ISO |
Eugenol results in increased expression of DNAJB4 mRNA |
CTD |
PMID:23999411 PMID:27965148 |
|
NCBI chr 2:241,129,346...241,159,272
Ensembl chr 2:241,130,340...241,159,089
|
|
G |
Dnase2 |
deoxyribonuclease 2, lysosomal |
increases expression |
ISO |
Eugenol results in increased expression of DNASE2A mRNA |
CTD |
PMID:15618236 |
|
NCBI chr19:23,244,656...23,247,376
Ensembl chr19:23,244,664...23,247,376
|
|
G |
Drd1 |
dopamine receptor D1 |
multiple interactions |
EXP |
[2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine binds to and results in increased activity of DRD1 protein] which results in increased susceptibility to Eugenol |
CTD |
PMID:9537685 |
|
NCBI chr17:10,540,440...10,544,971
Ensembl chr17:10,540,558...10,545,002
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
increases expression |
ISO |
Eugenol results in increased expression of DUSP1 mRNA |
CTD |
PMID:30806763 |
|
NCBI chr10:16,680,478...16,683,275
|
|
G |
E2f1 |
E2F transcription factor 1 |
decreases expression |
ISO |
Eugenol results in decreased expression of E2F1 mRNA; Eugenol results in decreased expression of E2F1 protein |
CTD |
PMID:15574415 |
|
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
|
|
G |
E2f2 |
E2F transcription factor 2 |
decreases expression |
ISO |
Eugenol results in decreased expression of E2F2 mRNA; Eugenol results in decreased expression of E2F2 protein |
CTD |
PMID:15574415 |
|
NCBI chr 5:148,399,193...148,422,595
Ensembl chr 5:148,399,642...148,421,217
|
|
G |
E2f3 |
E2F transcription factor 3 |
decreases expression |
ISO |
Eugenol results in decreased expression of E2F3 mRNA; Eugenol results in decreased expression of E2F3 protein |
CTD |
PMID:15574415 |
|
NCBI chr17:34,601,756...34,679,139
Ensembl chr17:34,601,830...34,676,253
|
|
G |
E2f4 |
E2F transcription factor 4 |
decreases expression |
ISO |
Eugenol results in decreased expression of E2F4 mRNA |
CTD |
PMID:15574415 |
|
NCBI chr19:33,174,396...33,181,806
Ensembl chr19:33,174,410...33,181,806
|
|
G |
E2f5 |
E2F transcription factor 5 |
decreases expression |
ISO |
Eugenol results in decreased expression of E2F5 mRNA |
CTD |
PMID:15574415 |
|
NCBI chr 2:86,997,331...87,012,908
Ensembl chr 2:86,997,332...87,012,990
|
|
G |
E2f6 |
E2F transcription factor 6 |
increases expression |
ISO |
Eugenol results in increased expression of E2F6 mRNA |
CTD |
PMID:15574415 |
|
NCBI chr 6:39,592,224...39,608,685
Ensembl chr 6:39,592,228...39,608,683
|
|
G |
Egfr |
epidermal growth factor receptor |
decreases expression increases expression |
ISO |
Eugenol results in decreased expression of EGFR protein Eugenol results in increased expression of EGFR mRNA |
CTD |
PMID:15618236 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Egr1 |
early growth response 1 |
multiple interactions |
ISO |
[[Eugenol results in increased activity of OR5D18 protein] which results in increased abundance of Cyclic AMP] which results in increased expression of EGR1 mRNA |
CTD |
PMID:12767924 |
|
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Egr2 |
early growth response 2 |
decreases expression |
ISO |
Eugenol results in decreased expression of EGR2 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr20:21,051,270...21,056,322
Ensembl chr20:21,051,277...21,055,562
|
|
G |
Emb |
embigin |
decreases expression |
ISO |
Eugenol results in decreased expression of EMB mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 2:49,070,509...49,125,042
Ensembl chr 2:49,069,087...49,125,050
|
|
G |
Epcam |
epithelial cell adhesion molecule |
decreases expression |
ISO |
Eugenol results in decreased expression of EPCAM protein Eugenol results in decreased expression of EPCAM mRNA; Eugenol results in decreased expression of EPCAM protein |
CTD |
PMID:31926151 |
|
NCBI chr 6:6,880,142...6,896,103
Ensembl chr 6:6,878,237...6,896,127
|
|
G |
Esr1 |
estrogen receptor 1 |
affects binding multiple interactions |
ISO |
Eugenol binds to ESR1 protein Eugenol inhibits the reaction [Estradiol binds to ESR1 protein] |
CTD |
PMID:12495555 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
affects binding multiple interactions |
ISO |
Eugenol binds to ESR2 protein Eugenol inhibits the reaction [Estradiol binds to ESR2 protein] |
CTD |
PMID:12495555 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
F13a1 |
coagulation factor XIII A1 chain |
decreases expression |
ISO |
Eugenol results in decreased expression of F13A1 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr17:27,815,723...27,992,494
Ensembl chr17:27,815,702...27,992,700
|
|
G |
Fasn |
fatty acid synthase |
decreases expression |
ISO |
Eugenol results in decreased expression of FASN mRNA |
CTD |
PMID:21870829 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fbxo9 |
f-box protein 9 |
decreases expression |
ISO |
Eugenol results in decreased expression of FBXO9 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 8:78,958,482...78,984,015
Ensembl chr 8:78,958,483...78,983,949
|
|
G |
Fcgr2b |
Fc gamma receptor 2B |
increases expression |
ISO |
Eugenol results in increased expression of FCGR2B mRNA |
CTD |
PMID:17374397 |
|
NCBI chr13:83,191,253...83,207,778
Ensembl chr13:83,193,163...83,207,778
|
|
G |
Fech |
ferrochelatase |
increases expression |
ISO |
Eugenol results in increased expression of FECH mRNA |
CTD |
PMID:20566472 |
|
NCBI chr18:57,945,123...57,978,327
Ensembl chr18:57,945,122...57,979,348
|
|
G |
Ferry3 |
FERRY endosomal RAB5 effector complex subunit 3 |
decreases expression |
ISO |
Eugenol results in decreased expression of FERRY3 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 4:159,772,693...159,809,322
Ensembl chr 4:159,772,786...159,806,382
|
|
G |
Flt1 |
Fms related receptor tyrosine kinase 1 |
multiple interactions |
EXP |
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of FLT1 mRNA] |
CTD |
PMID:20434464 |
|
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
|
|
G |
Fosl2 |
FOS like 2, AP-1 transcription factor subunit |
increases expression |
ISO |
Eugenol results in increased expression of FOSL2 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 6:24,297,898...24,319,219
Ensembl chr 6:24,300,956...24,320,034
|
|
G |
Ftl1 |
ferritin light chain 1 |
increases expression |
ISO |
Eugenol results in increased expression of FTL mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725 Ensembl chr 2:95,936,387...95,939,725
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
increases expression |
ISO |
Eugenol results in increased expression of G6PD mRNA |
CTD |
PMID:20566472 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
multiple interactions |
EXP |
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of GADD45A mRNA] |
CTD |
PMID:19851710 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
increases expression |
ISO |
Eugenol results in increased expression of GADD45B mRNA |
CTD |
PMID:15618236 |
|
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases expression |
ISO |
Eugenol results in increased expression of GCLC mRNA |
CTD |
PMID:20566472 PMID:26198647 PMID:30806763 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression |
ISO |
Eugenol results in increased expression of GCLM mRNA |
CTD |
PMID:20566472 PMID:26198647 PMID:27965148 PMID:30806763 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gpat3 |
glycerol-3-phosphate acyltransferase 3 |
increases expression |
ISO |
Eugenol results in increased expression of GPAT3 mRNA |
CTD |
PMID:26198647 |
|
NCBI chr14:8,715,367...8,768,051
Ensembl chr14:8,714,373...8,766,490
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
EXP |
Eugenol inhibits the reaction [Streptozocin results in increased expression of GPT protein] |
CTD |
PMID:38047382 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
increases expression |
ISO |
Eugenol results in increased expression of GPX3 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
increases expression |
ISO |
Eugenol results in increased expression of GSK3B mRNA |
CTD |
PMID:17374397 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Gsr |
glutathione-disulfide reductase |
increases expression |
ISO |
Eugenol results in increased expression of GSR mRNA |
CTD |
PMID:20566472 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gsta1 |
glutathione S-transferase alpha 1 |
decreases activity |
ISO |
Eugenol analog results in decreased activity of GSTA1 protein |
CTD |
PMID:8620581 |
|
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
|
|
G |
Gsta2 |
glutathione S-transferase alpha 2 |
increases expression decreases activity |
EXP |
Eugenol results in increased expression of GSTA2 protein Eugenol analog results in decreased activity of GSTA2 protein |
CTD |
PMID:8406240 PMID:8620581 |
|
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
|
|
G |
Gsta3 |
glutathione S-transferase alpha 3 |
decreases activity |
EXP |
Eugenol analog results in decreased activity of GSTA3 protein |
CTD |
PMID:8620581 |
|
NCBI chr 9:23,658,574...23,684,240
Ensembl chr 9:23,658,574...23,684,240
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
decreases activity |
ISO EXP |
Eugenol analog results in decreased activity of GSTM1 protein |
CTD |
PMID:8620581 |
|
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstm2 |
glutathione S-transferase mu 2 |
decreases activity |
EXP |
Eugenol analog results in decreased activity of GSTM2 protein |
CTD |
PMID:8620581 |
|
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
decreases activity |
ISO EXP |
Eugenol analog results in decreased activity of GSTP1 protein |
CTD |
PMID:8620581 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Heatr5b |
HEAT repeat containing 5B |
decreases expression |
ISO |
Eugenol results in decreased expression of HEATR5B mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 6:16,243,424...16,323,444
Ensembl chr 6:16,243,461...16,323,435
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
increases expression |
ISO |
Eugenol results in increased expression of HIF1A mRNA |
CTD |
PMID:20713136 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
decreases expression |
ISO |
Eugenol results in decreased expression of HMGCR mRNA |
CTD |
PMID:21870829 |
|
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
ISO |
Eugenol results in increased expression of HMOX1 mRNA |
CTD |
PMID:20566472 PMID:20713136 PMID:23445166 PMID:26244607 PMID:30806763 PMID:31967339 More...
|
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hnrnpa3 |
heterogeneous nuclear ribonucleoprotein A3 |
decreases expression |
ISO |
Eugenol results in decreased expression of HNRNPA3 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 3:60,578,574...60,588,755
Ensembl chr 3:60,578,673...60,588,306
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
decreases expression |
ISO |
Eugenol results in decreased expression of HRAS protein |
CTD |
PMID:20537511 |
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Hspa6l-ps1 |
heat shock protein family A (Hsp70) member 6 like, pseudogene 1 |
increases expression |
ISO |
Eugenol results in increased expression of HSPA6 mRNA |
CTD |
PMID:23999411 |
|
NCBI chr13:83,273,176...83,274,317
|
|
G |
Hsph1 |
heat shock protein family H (Hsp110) member 1 |
increases expression |
ISO |
Eugenol results in increased expression of HSPH1 mRNA |
CTD |
PMID:23999411 |
|
NCBI chr12:5,390,916...5,410,224
Ensembl chr12:5,390,922...5,410,224
|
|
G |
Ibsp |
integrin-binding sialoprotein |
decreases expression |
ISO |
Eugenol results in decreased expression of IBSP mRNA; Eugenol results in decreased expression of IBSP protein |
CTD |
PMID:21706355 |
|
NCBI chr14:5,439,825...5,452,570
Ensembl chr14:5,439,829...5,452,693
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
increases expression |
ISO |
Eugenol results in increased expression of ICAM1 mRNA; Eugenol results in increased expression of ICAM1 protein |
CTD |
PMID:30806763 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Idi1 |
isopentenyl-diphosphate delta isomerase 1 |
decreases expression |
ISO |
Eugenol results in decreased expression of IDI1 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357
|
|
G |
Ifng |
interferon gamma |
increases secretion multiple interactions |
ISO |
Eugenol results in increased secretion of IFNG protein [Methoxychlor co-treated with Eugenol] results in increased expression of IFNG protein; [Parathion co-treated with Eugenol] results in increased expression of IFNG protein |
CTD |
PMID:20920556 PMID:22245253 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
multiple interactions |
EXP |
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of IKBKB protein] |
CTD |
PMID:19851710 |
|
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
ISO |
[Eugenol co-treated with Acetylcysteine] inhibits the reaction [Nicotine results in decreased secretion of IL10 protein]; Eugenol inhibits the reaction [Nicotine results in decreased expression of IL10 mRNA] |
CTD |
PMID:21237301 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il12a |
interleukin 12A |
multiple interactions |
ISO |
Eugenol inhibits the reaction [Nicotine results in increased secretion of [IL12A protein co-treated with IL12B protein]] |
CTD |
PMID:21237301 |
|
NCBI chr 2:152,965,769...152,973,035
Ensembl chr 2:152,965,769...152,972,734
|
|
G |
Il12b |
interleukin 12B |
multiple interactions |
ISO |
Eugenol inhibits the reaction [Nicotine results in increased expression of IL12B mRNA]; Eugenol inhibits the reaction [Nicotine results in increased secretion of [IL12A protein co-treated with IL12B protein]] |
CTD |
PMID:21237301 |
|
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
|
|
G |
Il16 |
interleukin 16 |
multiple interactions increases secretion |
ISO |
Eugenol results in increased expression of and results in increased secretion of IL16 protein Eugenol results in increased secretion of IL16 protein |
CTD |
PMID:23624239 PMID:30806763 |
|
NCBI chr 1:137,617,702...137,718,022
Ensembl chr 1:137,617,944...137,718,130
|
|
G |
Il18 |
interleukin 18 |
increases expression |
ISO |
Eugenol results in increased expression of IL18 protein |
CTD |
PMID:23063874 |
|
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1a |
interleukin 1 alpha |
increases expression |
ISO |
Eugenol results in increased expression of IL1A mRNA |
CTD |
PMID:30806763 PMID:33715048 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions increases expression decreases expression |
ISO |
[Eugenol results in increased activity of sulforaphane] which results in decreased expression of IL1B; [sulforaphane results in increased activity of Eugenol] which results in decreased expression of IL1B; Eugenol inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IL1B protein]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of IL1B protein]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] Eugenol results in increased expression of IL1B mRNA Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein] Eugenol results in decreased expression of IL1B mRNA |
CTD |
PMID:12963494 PMID:17509409 PMID:20713136 PMID:21382956 PMID:21807015 PMID:21939359 More...
|
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1r2 |
interleukin 1 receptor type 2 |
increases expression |
ISO |
Eugenol results in increased expression of IL1R2 mRNA |
CTD |
PMID:20713136 PMID:30806763 |
|
NCBI chr 9:42,384,280...42,424,726
Ensembl chr 9:42,384,433...42,424,725
|
|
G |
Il2 |
interleukin 2 |
increases expression increases secretion |
ISO |
Eugenol results in increased expression of IL2 protein Eugenol results in increased secretion of IL2 protein |
CTD |
PMID:22245253 PMID:22381623 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il4r |
interleukin 4 receptor |
increases expression |
ISO |
Eugenol results in increased expression of IL4RA protein |
CTD |
PMID:22381623 |
|
NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980
|
|
G |
Il6 |
interleukin 6 |
multiple interactions increases secretion increases expression |
ISO EXP |
Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased secretion of IL6 protein] Eugenol results in increased secretion of IL6 protein Eugenol inhibits the reaction [Thioacetamide results in increased activity of IL6 protein] Eugenol results in increased expression of IL6 mRNA |
CTD |
PMID:20036707 PMID:20043298 PMID:21870829 PMID:22245253 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Il7r |
interleukin 7 receptor |
increases expression |
ISO |
Eugenol results in increased expression of IL7R mRNA |
CTD |
PMID:20713136 |
|
NCBI chr 2:58,452,393...58,477,757
Ensembl chr 2:58,454,217...58,477,757
|
|
G |
Inhba |
inhibin subunit beta A |
decreases expression |
ISO |
Eugenol results in decreased expression of INHBA mRNA |
CTD |
PMID:15618236 |
|
NCBI chr17:49,091,635...49,111,573
Ensembl chr17:49,095,920...49,108,982
|
|
G |
Ipcef1 |
interaction protein for cytohesin exchange factors 1 |
decreases expression |
ISO |
Eugenol results in decreased expression of IPCEF1 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 1:43,237,903...43,451,735
Ensembl chr 1:43,269,202...43,427,969
|
|
G |
Itga6 |
integrin subunit alpha 6 |
increases expression |
ISO |
Eugenol results in increased expression of ITGA6 mRNA |
CTD |
PMID:17936526 |
|
NCBI chr 3:56,604,512...56,689,428
Ensembl chr 3:56,617,268...56,689,428
|
|
G |
Itgb1 |
integrin subunit beta 1 |
increases expression |
ISO |
Eugenol results in increased expression of ITGB1 mRNA |
CTD |
PMID:17936526 |
|
NCBI chr19:56,705,123...56,753,199
Ensembl chr19:56,705,171...56,753,195
|
|
G |
Kcna5 |
potassium voltage-gated channel subfamily A member 5 |
decreases activity |
ISO |
Eugenol results in decreased activity of KCNA5 protein |
CTD |
PMID:17720863 |
|
NCBI chr 4:159,354,689...159,358,173
Ensembl chr 4:159,350,097...159,357,697
|
|
G |
Kcnj2 |
potassium inwardly-rectifying channel, subfamily J, member 2 |
decreases expression |
ISO |
Eugenol results in decreased expression of KCNJ2 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr10:96,060,834...96,071,397
Ensembl chr10:96,060,821...96,071,445
|
|
G |
Kif23 |
kinesin family member 23 |
decreases expression |
ISO |
Eugenol results in decreased expression of KIF23 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 8:62,397,908...62,425,162
Ensembl chr 8:62,397,948...62,425,072
|
|
G |
Maff |
MAF bZIP transcription factor F |
increases expression |
ISO |
Eugenol results in increased expression of MAFF mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
|
|
G |
Mafg |
MAF bZIP transcription factor G |
increases expression |
ISO |
Eugenol results in increased expression of MAFG mRNA |
CTD |
PMID:20566472 |
|
NCBI chr10:105,903,307...105,911,808
Ensembl chr10:105,903,237...105,912,026
|
|
G |
Mafk |
MAF bZIP transcription factor K |
increases expression |
ISO |
Eugenol results in increased expression of MAFK mRNA |
CTD |
PMID:20566472 |
|
NCBI chr12:14,834,628...14,856,414
Ensembl chr12:14,833,984...14,837,048 Ensembl chr12:14,833,984...14,837,048
|
|
G |
Mcts1 |
MCTS1, re-initiation and release factor |
decreases expression |
ISO |
Eugenol results in decreased expression of MCTS1 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr X:117,350,723...117,362,504
Ensembl chr X:117,350,889...117,362,504
|
|
G |
Me1 |
malic enzyme 1 |
increases expression |
ISO |
Eugenol results in increased expression of ME1 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
|
|
G |
Mgst1 |
microsomal glutathione S-transferase 1 |
increases expression |
ISO |
Eugenol results in increased expression of MGST1 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 4:171,029,666...171,044,893
Ensembl chr 4:171,029,630...171,044,892
|
|
G |
Mir146a |
microRNA 146a |
increases expression |
ISO |
Eugenol results in increased expression of MIR146A mRNA |
CTD |
PMID:37326882 |
|
NCBI chr10:27,848,516...27,848,610
Ensembl chr10:27,848,516...27,848,610
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions decreases expression |
EXP ISO |
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of and results in increased activity of MMP2 protein]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of MMP2 mRNA] Eugenol results in decreased expression of MMP2 mRNA |
CTD |
PMID:20434464 PMID:30518369 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions decreases expression |
EXP ISO |
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of and results in increased activity of MMP9 protein]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of MMP9 mRNA] Eugenol results in decreased expression of MMP9 mRNA |
CTD |
PMID:20434464 PMID:30518369 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
EXP |
Eugenol inhibits the reaction [Acetic Acid results in increased activity of MPO protein]; Eugenol inhibits the reaction [Thioacetamide results in increased activity of MPO protein] |
CTD |
PMID:20036707 PMID:33245926 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Mrpl35 |
mitochondrial ribosomal protein L35 |
decreases expression |
ISO |
Eugenol results in decreased expression of MRPL35 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 4:103,865,812...103,876,687
Ensembl chr 4:103,865,812...103,880,887
|
|
G |
Ms4a7 |
membrane spanning 4-domains A7 |
increases expression |
ISO |
Eugenol results in increased expression of MS4A7 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 1:207,969,117...207,984,743
Ensembl chr 1:207,968,761...207,983,260
|
|
G |
Mt3 |
metallothionein 3 |
increases expression |
ISO |
Eugenol results in increased expression of MT3 mRNA |
CTD |
PMID:15157811 |
|
NCBI chr19:10,848,754...10,850,158
Ensembl chr19:10,848,755...10,850,158
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
increases activity |
EXP |
Eugenol results in increased activity of MTOR protein |
CTD |
PMID:36007673 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Mxd1 |
max dimerization protein 1 |
increases expression |
ISO |
Eugenol results in increased expression of MXD1 mRNA |
CTD |
PMID:20713136 |
|
NCBI chr 4:119,097,353...119,118,080
Ensembl chr 4:119,097,353...119,117,751
|
|
G |
Myb |
MYB proto-oncogene, transcription factor |
decreases expression |
ISO |
Eugenol results in decreased expression of MYB mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 1:15,939,771...15,973,367
Ensembl chr 1:15,939,761...15,973,057
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
multiple interactions |
ISO |
Eugenol inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MYC protein] |
CTD |
PMID:20537511 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Nampt |
nicotinamide phosphoribosyltransferase |
increases expression |
ISO |
Eugenol results in increased expression of NAMPT mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 6:49,425,316...49,462,109
Ensembl chr 6:49,424,332...49,462,100
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
affects expression decreases expression multiple interactions |
ISO |
Eugenol affects the expression of NFE2L2 protein Eugenol results in decreased expression of NFE2L2 mRNA Eugenol promotes the reaction [NFE2L2 protein results in increased expression of NQO1 mRNA] |
CTD |
PMID:17275817 PMID:31967339 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions affects expression |
ISO EXP |
Eugenol inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] Eugenol affects the expression of NFKB1 mRNA Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of NFKB1 mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of NFKB1 protein] |
CTD |
PMID:10871845 PMID:19851710 PMID:20385217 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
EXP ISO |
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of NFKBIA mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of NFKBIA protein]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of NFKBIA protein modified form] Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of NFKBIA protein modified form]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein] |
CTD |
PMID:12963494 PMID:19851710 PMID:20043298 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of NOS2 protein]; Eugenol inhibits the reaction [Nicotine results in increased expression of NOS2 mRNA]; Eugenol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein] |
CTD |
PMID:20043298 PMID:21237301 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Notch1 |
notch receptor 1 |
decreases expression |
ISO |
Eugenol results in decreased expression of NOTCH1 protein Eugenol results in decreased expression of NOTCH1 mRNA; Eugenol results in decreased expression of NOTCH1 protein |
CTD |
PMID:31926151 |
|
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression increases activity multiple interactions |
ISO |
Eugenol results in increased expression of NQO1 mRNA; Eugenol results in increased expression of NQO1 protein Eugenol results in increased activity of NQO1 protein [Dicumarol results in decreased activity of NQO1 protein] inhibits the reaction [Eugenol results in increased expression of CD86 protein]; Eugenol promotes the reaction [NFE2L2 protein results in increased expression of NQO1 mRNA] |
CTD |
PMID:17275817 PMID:20566472 PMID:21742781 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
increases expression |
ISO |
Eugenol results in increased expression of NR1I2 mRNA |
CTD |
PMID:29933105 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nup88 |
nucleoporin 88 |
increases expression |
ISO |
Eugenol results in increased expression of NUP88 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr10:55,667,903...55,692,249
Ensembl chr10:55,667,906...55,692,257
|
|
G |
Or5d18 |
olfactory receptor family 5 subfamily D member 18 |
multiple interactions increases activity affects binding |
ISO |
[[Eugenol results in increased activity of OR5D18 protein] which results in increased abundance of Cyclic AMP] which results in increased expression of EGR1 mRNA; [Eugenol binds to and results in increased activity of OR5D18 protein] which results in increased abundance of Cyclic AMP; [Eugenol binds to and results in increased activity of OR5D18 protein] which results in increased transport of Calcium; [Eugenol binds to OR5D18 protein] which results in increased transport of Calcium; [Eugenol results in increased activity of OR5D18 protein] which results in increased abundance of Cyclic AMP; Eugenol binds to and results in increased activity of OR5D18 protein; isomethyleugenol inhibits the reaction [[Eugenol binds to OR5D18 protein] which results in increased transport of Calcium] |
CTD |
PMID:12767924 PMID:14685265 PMID:15716417 PMID:19723634 |
|
NCBI chr 3:73,516,522...73,517,463
Ensembl chr 3:73,516,364...73,519,858 Ensembl chr 3:73,516,364...73,519,858
|
|
G |
P2rx3 |
purinergic receptor P2X 3 |
multiple interactions |
EXP |
Eugenol inhibits the reaction [P2RX3 protein affects the activity of Adenosine Triphosphate] |
CTD |
PMID:19967073 |
|
NCBI chr 3:70,080,850...70,124,664
Ensembl chr 3:70,080,851...70,125,178
|
|
G |
Paics |
phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase |
decreases expression |
ISO |
Eugenol results in decreased expression of PAICS mRNA |
CTD |
PMID:17374397 |
|
NCBI chr14:31,199,086...31,232,731
Ensembl chr14:31,173,541...31,232,635
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
ISO |
Eugenol affects the reaction [Methylnitronitrosoguanidine affects the cleavage of PARP1 protein] |
CTD |
PMID:20434464 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions |
ISO EXP |
Eugenol inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PCNA protein] Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of PCNA mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of PCNA protein] |
CTD |
PMID:19851710 PMID:20043298 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pde4b |
phosphodiesterase 4B |
increases expression |
ISO |
Eugenol results in increased expression of PDE4B mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 5:116,799,819...117,369,155
Ensembl chr 5:116,799,971...117,367,696
|
|
G |
Pgd |
phosphogluconate dehydrogenase |
increases expression |
ISO |
Eugenol results in increased expression of PGD mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 5:159,582,746...159,598,945
Ensembl chr 5:159,561,271...159,742,778
|
|
G |
Picalm |
phosphatidylinositol binding clathrin assembly protein |
increases expression |
ISO |
Eugenol results in increased expression of PICALM mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 1:144,056,415...144,138,045
Ensembl chr 1:144,056,721...144,137,557
|
|
G |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
increases expression |
EXP ISO |
Eugenol results in increased expression of PIK3R1 mRNA |
CTD |
PMID:20724125 PMID:21870829 |
|
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
|
|
G |
Plat |
plasminogen activator, tissue type |
increases expression |
ISO |
Eugenol results in increased expression of PLAT mRNA |
CTD |
PMID:17374397 |
|
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
|
|
G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
increases expression |
ISO |
Eugenol results in increased expression of PMAIP1 mRNA |
CTD |
PMID:20713136 |
|
NCBI chr18:59,986,020...59,992,434
Ensembl chr18:59,986,017...59,992,429
|
|
G |
Pou5f1 |
POU class 5 homeobox 1 |
decreases expression |
ISO |
Eugenol results in decreased expression of POU5F1 protein Eugenol results in decreased expression of POU5F1 mRNA; Eugenol results in decreased expression of POU5F1 protein |
CTD |
PMID:31926151 |
|
NCBI chr20:3,223,128...3,227,891
Ensembl chr20:3,223,129...3,227,891
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions increases expression |
ISO |
Eugenol analog binds to and results in increased activity of PPARG protein Eugenol results in increased expression of PPARG mRNA 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Eugenol analog binds to and results in increased activity of PPARG protein]; Eugenol analog binds to and results in increased activity of PPARG protein |
CTD |
PMID:20064974 PMID:21870829 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppbp |
pro-platelet basic protein |
multiple interactions increases expression |
ISO |
Eugenol results in increased expression of and results in increased secretion of PPBP protein Eugenol results in increased expression of PPBP mRNA |
CTD |
PMID:23624239 |
|
NCBI chr14:17,302,326...17,303,130
Ensembl chr14:17,302,326...17,303,130
|
|
G |
Prdx3 |
peroxiredoxin 3 |
decreases expression |
ISO |
Eugenol results in decreased expression of PRDX3 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 1:260,001,642...260,014,064
Ensembl chr 1:260,001,637...260,014,111
|
|
G |
Ptger3 |
prostaglandin E receptor 3 |
decreases expression |
ISO |
Eugenol results in decreased expression of PTGER3 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 2:246,606,131...246,750,970
Ensembl chr 2:246,606,183...246,684,434
|
|
G |
Ptgr1 |
prostaglandin reductase 1 |
increases expression |
ISO |
Eugenol results in increased expression of PTGR1 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 5:73,784,000...73,802,624
Ensembl chr 5:73,784,009...73,802,666
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions increases expression decreases expression |
ISO EXP |
Eugenol inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 mRNA]; Eugenol inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 protein]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] Eugenol results in increased expression of PTGS2 mRNA Eugenol results in decreased expression of PTGS2 mRNA Eugenol inhibits the reaction [Thioacetamide results in increased expression of PTGS2 protein]; Eugenol inhibits the reaction [Thioacetamide results in increased expression of PTGS2] Eugenol inhibits the reaction [[Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein] which results in increased abundance of Dinoprostone]; Eugenol inhibits the reaction [[Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein] which results in increased metabolism of Arachidonic Acid]; Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 protein]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Eugenol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] |
CTD |
PMID:12757841 PMID:16101137 PMID:17509409 PMID:20036707 PMID:20043298 PMID:21807015 PMID:21939359 PMID:30806763 More...
|
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
decreases expression |
ISO |
Eugenol results in decreased expression of RB1 protein |
CTD |
PMID:22686307 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Reck |
reversion-inducing-cysteine-rich protein with kazal motifs |
multiple interactions |
EXP |
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of RECK mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of RECK protein] |
CTD |
PMID:20434464 |
|
NCBI chr 5:58,102,961...58,169,516
Ensembl chr 5:58,102,981...58,169,502
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO EXP |
Eugenol inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of RELA protein] Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of RELA mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of RELA protein] |
CTD |
PMID:10871845 PMID:19851710 PMID:20043298 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rgs1 |
regulator of G-protein signaling 1 |
increases expression |
ISO |
Eugenol results in increased expression of RGS1 mRNA |
CTD |
PMID:17374397 PMID:20713136 |
|
NCBI chr13:56,018,546...56,022,889
Ensembl chr13:56,018,554...56,022,984
|
|
G |
Rpl27a |
ribosomal protein L27A |
increases expression |
ISO |
Eugenol results in increased expression of RPL27A mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 1:163,539,732...163,542,771
|
|
G |
Rrm2b |
ribonucleotide reductase regulatory TP53 inducible subunit M2B |
increases expression |
ISO |
Eugenol results in increased expression of RRM2B mRNA |
CTD |
PMID:21704725 |
|
NCBI chr 7:69,077,024...69,108,742
Ensembl chr 7:69,078,291...69,108,633
|
|
G |
Sat1 |
spermidine/spermine N1-acetyl transferase 1 |
increases expression |
ISO |
Eugenol results in increased expression of SAT1 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr X:40,158,354...40,161,641
Ensembl chr X:40,157,046...40,196,813
|
|
G |
Sdc2 |
syndecan 2 |
increases expression |
ISO |
Eugenol results in increased expression of SDC2 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 7:64,127,185...64,239,885
Ensembl chr 7:64,127,110...64,241,081
|
|
G |
Septin11 |
septin 11 |
decreases expression |
ISO |
Eugenol results in decreased expression of SEPTIN11 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr14:14,844,759...14,990,856
Ensembl chr14:14,844,580...14,990,853
|
|
G |
Serpinb3 |
serpin family B member 3 |
increases expression |
ISO |
Eugenol results in increased expression of SERPINB3 mRNA |
CTD |
PMID:30806763 |
|
NCBI chr13:23,274,120...23,280,660
Ensembl chr13:23,274,484...23,313,682
|
|
G |
Slamf1 |
signaling lymphocytic activation molecule family member 1 |
decreases expression |
ISO |
Eugenol results in decreased expression of SLAMF1 mRNA |
CTD |
PMID:20713136 |
|
NCBI chr13:84,270,316...84,305,497
Ensembl chr13:84,270,316...84,305,497
|
|
G |
Slc16a10 |
solute carrier family 16 member 10 |
increases expression |
ISO |
Eugenol results in increased expression of SLC16A10 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr20:43,454,819...43,567,839
Ensembl chr20:43,459,709...43,567,839
|
|
G |
Slc2a3 |
solute carrier family 2 member 3 |
increases expression |
ISO |
Eugenol results in increased expression of SLC2A3 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 4:155,960,944...156,026,000
Ensembl chr 4:155,960,946...156,025,472
|
|
G |
Slc2a4 |
solute carrier family 2 member 4 |
increases expression |
ISO EXP |
Eugenol results in increased expression of SLC2A4 mRNA |
CTD |
PMID:20724125 PMID:21870829 |
|
NCBI chr10:54,666,015...54,671,581
Ensembl chr10:54,666,015...54,671,565
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
increases expression |
ISO |
Eugenol results in increased expression of SLC7A11 mRNA |
CTD |
PMID:26198647 PMID:30806763 |
|
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
|
|
G |
Sod1 |
superoxide dismutase 1 |
increases expression decreases expression multiple interactions |
ISO |
Eugenol results in increased expression of SOD1 mRNA Eugenol results in decreased expression of SOD1 mRNA; Eugenol results in decreased expression of SOD1 protein Acetylcysteine promotes the reaction [Eugenol results in decreased expression of SOD1 mRNA]; Glutathione promotes the reaction [Eugenol results in decreased expression of SOD1 mRNA] |
CTD |
PMID:16101137 PMID:20566472 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
increases expression decreases expression multiple interactions |
ISO |
Eugenol results in increased expression of SOD2 mRNA Eugenol results in decreased expression of SOD2 mRNA; Eugenol results in decreased expression of SOD2 protein Acetylcysteine promotes the reaction [Eugenol results in decreased expression of SOD2 mRNA]; Glutathione promotes the reaction [Eugenol results in decreased expression of SOD2 mRNA] |
CTD |
PMID:16101137 PMID:20566472 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sod3 |
superoxide dismutase 3 |
increases expression |
ISO |
Eugenol results in increased expression of SOD3 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr14:58,610,104...58,615,845
Ensembl chr14:58,609,958...58,615,990
|
|
G |
Sqstm1 |
sequestosome 1 |
increases expression |
ISO |
Eugenol results in increased expression of SQSTM1 mRNA |
CTD |
PMID:26198647 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Srxn1 |
sulfiredoxin 1 |
increases expression |
ISO |
Eugenol results in increased expression of SRXN1 mRNA |
CTD |
PMID:20566472 PMID:26198647 |
|
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
decreases expression |
ISO |
Eugenol results in decreased expression of STAT1 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Stat4 |
signal transducer and activator of transcription 4 |
increases expression |
ISO |
Eugenol results in increased expression of STAT4 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 9:49,472,660...49,588,540
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Stat5b |
signal transducer and activator of transcription 5B |
increases expression |
ISO |
Eugenol results in increased expression of STAT5B mRNA |
CTD |
PMID:17374397 |
|
NCBI chr10:85,704,841...85,775,856
Ensembl chr10:85,705,670...85,775,668
|
|
G |
Sult1c3 |
sulfotransferase family 1C member 3 |
increases sulfation |
ISO |
SULT1C1 protein results in increased sulfation of Eugenol |
CTD |
PMID:9560327 |
|
NCBI chr 9:7,221,580...7,266,991
Ensembl chr 9:7,221,578...7,267,030
|
|
G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
multiple interactions |
EXP |
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of TIMP2 mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of TIMP2 protein] |
CTD |
PMID:20434464 |
|
NCBI chr10:103,541,199...103,590,611
Ensembl chr10:103,531,505...103,590,611
|
|
G |
Tlr4 |
toll-like receptor 4 |
increases expression |
ISO |
Eugenol results in increased expression of TLR4 mRNA |
CTD |
PMID:17936526 |
|
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression affects expression |
ISO EXP |
Eugenol inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of TNF protein]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of TNF protein]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Eugenol inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] Eugenol results in increased expression of TNF mRNA Eugenol affects the expression of TNF mRNA Eugenol inhibits the reaction [Chlorpyrifos results in increased expression of TNF protein]; Eugenol inhibits the reaction [Thioacetamide results in increased activity of TNF protein] [Methoxychlor co-treated with Eugenol] results in increased expression of TNF protein; [Parathion co-treated with Eugenol] results in increased expression of TNF protein; Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased secretion of TNF protein]; Eugenol inhibits the reaction [Bacterial Toxins results in increased secretion of TNF protein]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Eugenol inhibits the reaction [Nicotine results in increased expression of TNF mRNA]; Eugenol inhibits the reaction [Nicotine results in increased secretion of TNF protein] |
CTD |
PMID:10871845 PMID:12963494 PMID:17509409 PMID:20036707 PMID:20043298 PMID:20385217 PMID:20639367 PMID:20920556 PMID:21237301 PMID:21807015 PMID:21870829 PMID:30806763 PMID:32096903 More...
|
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfaip3 |
TNF alpha induced protein 3 |
increases expression |
ISO |
Eugenol results in increased expression of TNFAIP3 mRNA |
CTD |
PMID:20713136 |
|
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
|
|
G |
Tnfaip6 |
TNF alpha induced protein 6 |
increases expression |
ISO |
Eugenol results in increased expression of TNFAIP6 mRNA |
CTD |
PMID:17374397 PMID:20713136 |
|
NCBI chr 3:36,502,250...36,521,652
Ensembl chr 3:36,502,188...36,521,649
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions increases mutagenesis increases expression |
EXP ISO |
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of TP53 protein] Eugenol results in increased mutagenesis of TP53 gene Eugenol results in increased expression of TRP53 mRNA; Eugenol results in increased expression of TRP53 protein Eugenol promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 protein] |
CTD |
PMID:15576237 PMID:19851710 PMID:20043298 PMID:20537511 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tp63 |
tumor protein p63 |
decreases expression |
ISO |
Eugenol results in decreased expression of TP63 mRNA |
CTD |
PMID:17936526 |
|
NCBI chr11:74,838,858...75,049,764
Ensembl chr11:74,838,859...75,049,398
|
|
G |
Trpa1 |
transient receptor potential cation channel, subfamily A, member 1 |
multiple interactions increases activity |
EXP |
[2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide binds to and results in decreased activity of TRPA1 protein] which results in decreased susceptibility to Eugenol Eugenol results in increased activity of TRPA1 protein |
CTD |
PMID:22426238 |
|
NCBI chr 5:4,379,862...4,434,133
Ensembl chr 5:4,379,999...4,433,570
|
|
G |
Trpv3 |
transient receptor potential cation channel, subfamily V, member 3 |
multiple interactions increases activity |
ISO EXP |
Eugenol binds to and results in increased activity of TRPV3 protein [Eugenol binds to and results in increased activity of TRPV3 protein] which results in increased transport of Calcium; Eugenol binds to and results in increased activity of TRPV3 protein [Eugenol results in increased activity of TRPV3 protein] which results in increased transport of Calcium |
CTD |
PMID:16617338 PMID:20086034 PMID:21593771 |
|
NCBI chr10:57,883,546...57,915,865
Ensembl chr10:57,883,546...57,913,296
|
|
G |
Txn2 |
thioredoxin 2 |
increases expression |
ISO |
Eugenol results in increased expression of TXN2 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 7:109,496,772...109,510,378
Ensembl chr 7:109,496,761...109,510,359
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
increases expression |
ISO |
Eugenol results in increased expression of TXNRD1 mRNA |
CTD |
PMID:20566472 PMID:23445166 |
|
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
|
|
G |
Txnrd2 |
thioredoxin reductase 2 |
increases expression |
ISO |
Eugenol results in increased expression of TXNRD2 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr11:82,519,996...82,568,156
Ensembl chr11:82,519,999...82,568,156
|
|
G |
Ugdh |
UDP-glucose 6-dehydrogenase |
increases expression |
ISO |
Eugenol results in increased expression of UGDH mRNA |
CTD |
PMID:16292757 |
|
NCBI chr14:42,848,704...42,872,351
Ensembl chr14:42,848,854...42,872,354
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
increases glucuronidation |
ISO |
UGT1A1 protein results in increased glucuronidation of Eugenol |
CTD |
PMID:14557274 |
|
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a6 |
UDP glucuronosyltransferase family 1 member A6 |
increases expression |
ISO |
Eugenol results in increased expression of UGT1A6 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 9:88,747,213...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a9 |
UDP glucuronosyltransferase family 1 member A9 |
increases glucuronidation |
ISO |
UGT1A9 protein results in increased glucuronidation of Eugenol |
CTD |
PMID:14557274 |
|
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt2b1 |
UDP glucuronosyltransferase 2 family, polypeptide B1 |
increases metabolic processing |
ISO |
UGT2B17 protein results in increased metabolism of Eugenol |
CTD |
PMID:8798464 |
|
NCBI chr14:21,024,035...21,035,784
Ensembl chr14:21,024,006...21,035,986
|
|
G |
Ugt2b15 |
UDP glucuronosyltransferase family 2 member B15 |
increases metabolic processing |
EXP |
UGT2B15 protein results in increased metabolism of Eugenol |
CTD |
PMID:7574722 |
|
NCBI chr14:20,768,015...20,783,599
Ensembl chr14:20,768,015...20,783,589
|
|
G |
Vdr |
vitamin D receptor |
increases expression |
ISO |
Eugenol results in increased expression of VDR mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
|
|
G |
Zbtb17 |
zinc finger and BTB domain containing 17 |
decreases expression |
ISO |
Eugenol results in decreased expression of ZBTB17 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 5:153,753,508...153,774,613
Ensembl chr 5:153,753,569...153,774,609
|
|
|
G |
Aass |
aminoadipate-semialdehyde synthase |
decreases expression |
ISO |
methyleugenol results in decreased expression of AASS mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:51,606,461...51,663,136
Ensembl chr 4:51,606,462...51,663,136
|
|
G |
Abat |
4-aminobutyrate aminotransferase |
decreases expression |
ISO |
methyleugenol results in decreased expression of ABAT mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:6,996,688...7,092,835
Ensembl chr10:6,999,819...7,092,835
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ABCA1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Abca6 |
ATP binding cassette subfamily A member 6 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ABCA6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:95,142,805...95,212,087
Ensembl chr10:95,142,966...95,211,530
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ABCB11 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcb4 |
ATP binding cassette subfamily B member 4 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ABCB4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
|
|
G |
Abcc6 |
ATP binding cassette subfamily C member 6 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ABCC6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:96,447,224...96,501,464
Ensembl chr 1:96,447,251...96,501,464
|
|
G |
Abcc9 |
ATP binding cassette subfamily C member 9 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ABCC9 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:175,531,854...175,655,849
Ensembl chr 4:175,532,547...175,655,356
|
|
G |
Abcg5 |
ATP binding cassette subfamily G member 5 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ABCG5 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563
|
|
G |
Abcg8 |
ATP binding cassette subfamily G member 8 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ABCG8 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:9,945,629...9,964,912
Ensembl chr 6:9,945,629...9,964,912
|
|
G |
Abhd2 |
abhydrolase domain containing 2, acylglycerol lipase |
decreases expression |
ISO |
methyleugenol results in decreased expression of ABHD2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:133,217,403...133,298,564
Ensembl chr 1:133,217,375...133,299,061
|
|
G |
Acaa1a |
acetyl-CoA acyltransferase 1A |
decreases expression |
ISO |
methyleugenol results in decreased expression of ACAA1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:119,079,401...119,088,626
Ensembl chr 8:119,079,775...119,088,624
|
|
G |
Acacb |
acetyl-CoA carboxylase beta |
decreases expression |
ISO |
methyleugenol results in decreased expression of ACACB mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:42,365,800...42,477,651
Ensembl chr12:42,366,548...42,457,655
|
|
G |
Acat2 |
acetyl-CoA acetyltransferase 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ACAT2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:47,695,833...47,713,879
Ensembl chr 1:47,695,788...47,752,821
|
|
G |
Ache |
acetylcholinesterase |
increases expression |
ISO |
methyleugenol results in increased expression of ACHE mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Acmsd |
aminocarboxymuconate semialdehyde decarboxylase |
decreases expression |
ISO |
methyleugenol results in decreased expression of ACMSD mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:39,200,412...39,245,954
Ensembl chr13:39,200,314...39,245,209
|
|
G |
Acot1 |
acyl-CoA thioesterase 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ACOT1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:103,636,173...103,644,167
Ensembl chr 6:103,636,041...103,644,163
|
|
G |
Acot11 |
acyl-CoA thioesterase 11 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ACOT11 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:121,523,833...121,581,699
Ensembl chr 5:121,527,435...121,581,538
|
|
G |
Acot12 |
acyl-CoA thioesterase 12 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ACOT12 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:22,986,867...23,027,538
Ensembl chr 2:22,986,626...23,027,536
|
|
G |
Acox2 |
acyl-CoA oxidase 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ACOX2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:16,660,584...16,692,160
Ensembl chr15:16,660,272...16,692,160
|
|
G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ACSL1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541
|
|
G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ACSL4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr X:105,942,794...106,006,573
Ensembl chr X:105,942,799...106,006,427
|
|
G |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ACSL5 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:254,289,513...254,336,608
Ensembl chr 1:254,292,521...254,336,607
|
|
G |
Acsm2 |
acyl-CoA synthetase medium-chain family member 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ACSM2A mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:173,916,368...173,955,116
Ensembl chr 1:173,916,368...173,955,116
|
|
G |
Acsm3 |
acyl-CoA synthetase medium-chain family member 3 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ACSM3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:174,133,260...174,159,966
Ensembl chr 1:174,133,288...174,160,184
|
|
G |
Acsm5 |
acyl-CoA synthetase medium-chain family member 5 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ACSM5 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:173,870,873...173,896,838
Ensembl chr 1:173,863,041...173,898,588
|
|
G |
Acss1 |
acyl-CoA synthetase short-chain family member 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ACSS1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:139,450,383...139,500,325
Ensembl chr 3:139,450,383...139,500,325
|
|
G |
Acss2 |
acyl-CoA synthetase short-chain family member 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ACSS2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:144,003,808...144,047,452
Ensembl chr 3:144,004,336...144,059,675
|
|
G |
Actl10 |
actin-like 10 |
increases expression |
ISO |
methyleugenol results in increased expression of ACTL10 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:143,057,061...143,058,561
Ensembl chr 3:143,057,402...143,058,442
|
|
G |
Acyp2 |
acylphosphatase 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ACYP2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:104,201,894...104,371,415
Ensembl chr14:104,201,895...104,371,386
|
|
G |
Adam19 |
ADAM metallopeptidase domain 19 |
increases expression |
ISO |
methyleugenol results in increased expression of ADAM19 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:30,491,362...30,583,115
Ensembl chr10:30,491,405...30,583,105
|
|
G |
Adamts17 |
ADAM metallopeptidase with thrombospondin type 1 motif, 17 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ADAMTS17 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:120,445,800...120,768,204
Ensembl chr 1:120,445,749...120,768,202
|
|
G |
Adamts3 |
ADAM metallopeptidase with thrombospondin type 1, motif 3 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ADAMTS3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:18,231,128...18,437,771
Ensembl chr14:18,231,165...18,435,556
|
|
G |
Adamts6 |
ADAM metallopeptidase with thrombospondin type 1 motif, 6 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ADAMTS6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:35,421,483...35,633,305
Ensembl chr 2:35,421,510...35,633,298
|
|
G |
Adamtsl3 |
ADAMTS-like 3 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ADAMTSL3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:136,288,793...136,596,986
Ensembl chr 1:136,288,793...136,596,986
|
|
G |
Adarb2 |
adenosine deaminase RNA specific B2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ADARB2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:61,750,437...62,300,984
Ensembl chr17:61,756,067...62,300,831
|
|
G |
Adcy5 |
adenylate cyclase 5 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ADCY5 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:65,471,612...65,618,877
Ensembl chr11:65,471,612...65,618,974
|
|
G |
Adcy8 |
adenylate cyclase 8 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ADCY8 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:96,417,310...96,665,911
Ensembl chr 7:96,417,324...96,665,911
|
|
G |
Adgrf4 |
adhesion G protein-coupled receptor F4 |
increases expression |
ISO |
methyleugenol results in increased expression of ADGRF4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:18,272,050...18,303,219
Ensembl chr 9:18,272,050...18,303,217
|
|
G |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
increases expression |
ISO |
methyleugenol results in increased expression of ADGRG1 mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr19:10,003,963...10,041,122
Ensembl chr19:10,003,975...10,041,108
|
|
G |
Adgrg7 |
adhesion G protein-coupled receptor G7 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ADGRG7 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:43,808,101...43,877,539
Ensembl chr11:43,813,801...43,876,316
|
|
G |
Adgrv1 |
adhesion G protein-coupled receptor V1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ADGRV1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:11,331,434...11,911,713
Ensembl chr 2:11,331,442...11,911,688
|
|
G |
Adh4 |
alcohol dehydrogenase 4 (class II), pi polypeptide |
decreases expression |
ISO |
methyleugenol results in decreased expression of ADH4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:226,948,717...226,966,747
Ensembl chr 2:226,947,466...226,987,591
|
|
G |
Adh6 |
alcohol dehydrogenase 6 (class V) |
decreases expression |
ISO |
methyleugenol results in decreased expression of ADH6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:226,903,208...226,934,564
Ensembl chr 2:226,903,250...226,934,534
|
|
G |
Adk |
adenosine kinase |
decreases expression |
ISO |
methyleugenol results in decreased expression of ADK mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:2,863,241...3,246,453
Ensembl chr15:2,863,244...3,246,510
|
|
G |
Adra1a |
adrenoceptor alpha 1A |
decreases expression |
ISO |
methyleugenol results in decreased expression of ADRA1A mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:40,830,125...40,935,902
Ensembl chr15:40,832,534...40,927,500
|
|
G |
Aff2 |
ALF transcription elongation factor 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of AFF2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr X:147,928,130...148,432,484
Ensembl chr X:147,928,407...148,429,995
|
|
G |
Aff3 |
ALF transcription elongation factor 3 |
decreases expression |
ISO |
methyleugenol results in decreased expression of AFF3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:40,399,099...40,856,716
Ensembl chr 9:40,404,375...40,857,247
|
|
G |
Afg1l |
AFG1 like ATPase |
decreases expression |
ISO |
methyleugenol results in decreased expression of AFG1L mRNA |
CTD |
PMID:32234424 |
|
NCBI chr20:45,798,344...45,967,997
Ensembl chr20:45,798,349...45,967,906
|
|
G |
Afm |
afamin |
decreases expression |
ISO |
methyleugenol results in decreased expression of AFM mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:17,531,022...17,563,868
Ensembl chr14:17,531,024...17,563,870
|
|
G |
Agmo |
alkylglycerol monooxygenase |
decreases expression |
ISO |
methyleugenol results in decreased expression of AGMO mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:53,986,236...54,317,838
Ensembl chr 6:53,986,292...54,317,623
|
|
G |
Agpat2 |
1-acylglycerol-3-phosphate O-acyltransferase 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of AGPAT2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:9,416,837...9,428,567
Ensembl chr 3:9,416,843...9,428,371
|
|
G |
Agr2 |
anterior gradient 2, protein disulphide isomerase family member |
increases expression |
ISO |
methyleugenol results in increased expression of AGR2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:52,708,602...52,729,378
Ensembl chr 6:52,708,602...52,729,371
|
|
G |
Agt |
angiotensinogen |
decreases expression |
ISO |
methyleugenol results in decreased expression of AGT mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Agxt |
alanine--glyoxylate aminotransferase |
decreases expression |
ISO |
methyleugenol results in decreased expression of AGXT mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:93,675,384...93,685,337
Ensembl chr 9:93,675,384...93,685,336
|
|
G |
Agxt2 |
alanine-glyoxylate aminotransferase 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of AGXT2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:59,336,252...59,377,664
Ensembl chr 2:59,336,283...59,377,926
|
|
G |
Ahsg |
alpha-2-HS-glycoprotein |
decreases expression |
ISO |
methyleugenol results in decreased expression of AHSG mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:78,121,388...78,127,998
Ensembl chr11:78,117,918...78,145,999
|
|
G |
Aig1 |
androgen-induced 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of AIG1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:8,046,430...8,269,276
Ensembl chr 1:8,046,430...8,269,084
|
|
G |
Akap12 |
A-kinase anchoring protein 12 |
increases expression |
ISO |
methyleugenol results in increased expression of AKAP12 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:40,730,123...40,819,863
Ensembl chr 1:40,730,123...40,819,886
|
|
G |
Akap6 |
A-kinase anchoring protein 6 |
decreases expression |
ISO |
methyleugenol results in decreased expression of AKAP6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:70,184,101...70,624,369
Ensembl chr 6:70,184,175...70,619,738
|
|
G |
Akr1b1 |
aldo-keto reductase family 1 member B1 |
increases expression |
ISO |
methyleugenol results in increased expression of AKR1B1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
increases expression |
ISO |
methyleugenol results in increased expression of AKR1B10 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
|
|
G |
Akr1b8 |
aldo-keto reductase family 1, member B8 |
increases expression |
ISO |
methyleugenol results in increased expression of AKR1B15 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:62,997,241...63,009,815
Ensembl chr 4:62,997,161...63,010,097
|
|
G |
Akr1d1 |
aldo-keto reductase family 1, member D1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of AKR1D1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:66,154,246...66,187,505
Ensembl chr 4:66,154,248...66,186,372
|
|
G |
Akr7a3 |
aldo-keto reductase family 7 member A3 |
decreases expression |
ISO |
methyleugenol results in decreased expression of AKR7A3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:151,590,968...151,601,394
Ensembl chr 5:151,584,479...151,601,394
|
|
G |
Alb |
albumin |
decreases expression |
ISO |
methyleugenol results in decreased expression of ALB mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Aldh3a1 |
aldehyde dehydrogenase 3 family, member A1 |
increases expression |
ISO |
methyleugenol results in increased expression of ALDH3A1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:45,892,993...45,902,680
Ensembl chr10:45,892,924...45,902,681
|
|
G |
Aldh4a1 |
aldehyde dehydrogenase 4 family, member A1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ALDH4A1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:151,880,002...151,905,491
Ensembl chr 5:151,830,701...151,925,345
|
|
G |
Aldh6a1 |
aldehyde dehydrogenase 6 family, member A1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ALDH6A1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:104,077,975...104,098,636
Ensembl chr 6:104,077,979...104,098,656
|
|
G |
Aldh8a1 |
aldehyde dehydrogenase 8 family, member A1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ALDH8A1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:16,183,940...16,203,385
Ensembl chr 1:16,183,940...16,203,385
|
|
G |
Aldob |
aldolase, fructose-bisphosphate B |
decreases expression |
ISO |
methyleugenol results in decreased expression of ALDOB mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:63,889,045...63,902,086
Ensembl chr 5:63,889,046...63,902,116
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
increases expression |
ISO |
methyleugenol results in increased expression of ALOX5 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
|
|
G |
Alpk2 |
alpha-kinase 2 |
increases expression |
ISO |
methyleugenol results in increased expression of ALPK2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr18:58,775,603...58,906,150
Ensembl chr18:58,775,605...58,906,258
|
|
G |
Ambp |
alpha-1-microglobulin/bikunin precursor |
decreases expression |
ISO |
methyleugenol results in decreased expression of AMBP mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:76,568,094...76,578,416
Ensembl chr 5:76,568,094...76,578,331
|
|
G |
Amotl1 |
angiomotin-like 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of AMOTL1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:11,348,651...11,467,564
Ensembl chr 8:11,353,674...11,467,573
|
|
G |
Ang |
angiogenin |
decreases expression |
ISO |
methyleugenol results in decreased expression of ANG mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:24,312,711...24,323,361
|
|
G |
Angptl3 |
angiopoietin-like 3 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ANGPTL3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:113,703,007...113,710,044
Ensembl chr 5:113,703,012...113,709,957
|
|
G |
Angptl8 |
angiopoietin-like 8 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ANGPTL8 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:20,376,462...20,378,488
Ensembl chr 8:20,376,462...20,378,490
|
|
G |
Ank1 |
ankyrin 1 |
increases expression |
ISO |
methyleugenol results in increased expression of ANK1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:68,876,294...69,054,963
Ensembl chr16:68,877,504...69,054,759
|
|
G |
Ank2 |
ankyrin 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ANK2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:215,378,028...215,954,015
Ensembl chr 2:215,379,680...215,862,923
|
|
G |
Ankrd1 |
ankyrin repeat domain 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ANKRD1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:233,815,851...233,834,891
Ensembl chr 1:233,815,851...233,834,919
|
|
G |
Ankrd2 |
ankyrin repeat domain 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ANKRD2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:240,847,111...240,856,563
Ensembl chr 1:240,847,072...240,856,566
|
|
G |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
decreases expression |
ISO |
methyleugenol results in decreased expression of ANKS1B mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:24,313,339...25,479,307
Ensembl chr 7:24,312,843...25,477,693
|
|
G |
Ano1 |
anoctamin 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ANO1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:199,751,439...199,900,099
Ensembl chr 1:199,751,439...199,900,069
|
|
G |
Ano4 |
anoctamin 4 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ANO4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:23,329,015...23,738,423
Ensembl chr 7:23,329,070...23,738,434
|
|
G |
Anxa10 |
annexin A10 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ANXA10 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:27,738,712...27,805,648
Ensembl chr16:27,738,712...27,805,648
|
|
G |
Anxa3 |
annexin A3 |
increases expression |
ISO |
methyleugenol results in increased expression of ANXA3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:12,727,708...12,781,717
Ensembl chr14:12,719,795...12,781,617
|
|
G |
Aoc1 |
amine oxidase, copper containing 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of AOC1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:77,812,260...77,831,846
Ensembl chr 4:77,812,260...77,831,840
|
|
G |
Apba1 |
amyloid beta precursor protein binding family A member 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of APBA1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:221,363,769...221,569,496
Ensembl chr 1:221,363,778...221,566,553
|
|
G |
Apbb1ip |
amyloid beta precursor protein binding family B member 1 interacting protein |
decreases expression |
ISO |
methyleugenol results in decreased expression of APBB1IP mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:84,941,404...85,033,020
Ensembl chr17:84,982,243...85,033,010
|
|
G |
Apcdd1l |
APC down-regulated 1 like |
increases expression |
ISO |
methyleugenol results in increased expression of APCDD1L mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:162,587,484...162,658,362
Ensembl chr 3:162,582,252...162,658,073
|
|
G |
Apcs |
amyloid P component, serum |
decreases expression |
ISO |
methyleugenol results in decreased expression of APCS mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:85,373,219...85,374,195
Ensembl chr13:85,373,220...85,374,298
|
|
G |
Apmap |
adipocyte plasma membrane associated protein |
decreases expression |
ISO |
methyleugenol results in decreased expression of APMAP mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:139,409,021...139,437,296
Ensembl chr 3:139,409,022...139,437,341
|
|
G |
Apoa1 |
apolipoprotein A1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of APOA1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
|
|
G |
Apoa4 |
apolipoprotein A4 |
decreases expression |
ISO |
methyleugenol results in decreased expression of APOA4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:46,539,083...46,541,464
Ensembl chr 8:46,539,082...46,541,469
|
|
G |
Apoa5 |
apolipoprotein A5 |
decreases expression |
ISO |
methyleugenol results in decreased expression of APOA5 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:46,561,180...46,563,818
Ensembl chr 8:46,561,229...46,563,816
|
|
G |
Apoc3 |
apolipoprotein C3 |
decreases expression |
ISO |
methyleugenol results in decreased expression of APOC3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:46,531,478...46,533,658
Ensembl chr 8:46,531,478...46,533,583
|
|
G |
Apoh |
apolipoprotein H |
decreases expression |
ISO |
methyleugenol results in decreased expression of APOH mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:93,342,435...93,356,334
Ensembl chr10:93,310,977...93,356,329
|
|
G |
Apom |
apolipoprotein M |
decreases expression |
ISO |
methyleugenol results in decreased expression of APOM mRNA |
CTD |
PMID:32234424 |
|
NCBI chr20:3,690,950...3,693,550
Ensembl chr20:3,688,413...3,693,550
|
|
G |
Aqp4 |
aquaporin 4 |
decreases expression |
ISO |
methyleugenol results in decreased expression of AQP4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr18:6,507,903...6,524,558
Ensembl chr18:6,507,903...6,524,856
|
|
G |
Aqp9 |
aquaporin 9 |
decreases expression |
ISO |
methyleugenol results in decreased expression of AQP9 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:71,797,231...71,837,485
Ensembl chr 8:71,797,234...71,837,395
|
|
G |
Arb2a |
ARB2 cotranscriptional regulator A |
decreases expression |
ISO |
methyleugenol results in decreased expression of ARB2A mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:7,553,873...8,018,183
Ensembl chr 2:7,553,891...8,018,162
|
|
G |
Arg1 |
arginase 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ARG1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Arhgap6 |
Rho GTPase activating protein 6 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ARHGAP6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr X:24,953,464...25,490,003
Ensembl chr X:24,953,464...25,488,663
|
|
G |
Arhgef37 |
Rho guanine nucleotide exchange factor 37 |
increases expression |
ISO |
methyleugenol results in increased expression of ARHGEF37 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr18:54,935,256...55,001,017
Ensembl chr18:54,949,110...55,000,669
|
|
G |
Arl14 |
ARF like GTPase 14 |
increases expression |
ISO |
methyleugenol results in increased expression of ARL14 mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr 2:153,468,863...153,470,102
Ensembl chr 2:153,468,977...153,469,555
|
|
G |
Arrb1 |
arrestin, beta 1 |
increases expression |
ISO |
methyleugenol results in increased expression of ARRB1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:153,837,964...153,912,111
Ensembl chr 1:153,838,078...153,904,061
|
|
G |
Arsb |
arylsulfatase B |
decreases expression |
ISO |
methyleugenol results in decreased expression of ARSB mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:25,002,210...25,162,675
Ensembl chr 2:25,002,346...25,162,671
|
|
G |
Art3 |
ADP-ribosyltransferase 3 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ART3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:15,637,230...15,719,442
Ensembl chr14:15,637,237...15,665,407
|
|
G |
Arvcf |
ARVCF, delta catenin family member |
increases expression |
ISO |
methyleugenol results in increased expression of ARVCF mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:82,588,137...82,645,832
Ensembl chr11:82,587,881...82,645,805
|
|
G |
Asb4 |
ankyrin repeat and SOCS box-containing 4 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ASB4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:33,506,992...33,544,630
Ensembl chr 4:33,506,992...33,544,630
|
|
G |
Asgr1 |
asialoglycoprotein receptor 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ASGR1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:54,775,727...54,779,642
Ensembl chr10:54,776,024...54,779,631
|
|
G |
Aspdh |
aspartate dehydrogenase domain containing |
decreases expression |
ISO |
methyleugenol results in decreased expression of ASPDH mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:94,956,327...94,960,722
Ensembl chr 1:94,958,316...94,960,722
|
|
G |
Atl1 |
atlastin GTPase 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ATL1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:88,377,168...88,475,242
Ensembl chr 6:88,377,239...88,475,204
|
|
G |
Atm |
ATM serine/threonine kinase |
increases phosphorylation decreases expression |
ISO EXP |
methyleugenol results in increased phosphorylation of ATM protein methyleugenol results in decreased expression of ATM mRNA |
CTD |
PMID:26011634 PMID:28818686 |
|
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Atp13a4 |
ATPase 13A4 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ATP13A4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:71,222,196...71,359,933
Ensembl chr11:71,226,161...71,359,933
|
|
G |
Atp2b2 |
ATPase plasma membrane Ca2+ transporting 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ATP2B2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:146,894,602...147,208,060
Ensembl chr 4:146,896,332...147,140,665
|
|
G |
Atp8b4 |
ATPase phospholipid transporting 8B4 (putative) |
decreases expression |
ISO |
methyleugenol results in decreased expression of ATP8B4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:113,554,979...113,757,635
Ensembl chr 3:113,556,192...113,757,225
|
|
G |
Atr |
ATR serine/threonine kinase |
increases phosphorylation |
ISO |
methyleugenol results in increased phosphorylation of ATR protein |
CTD |
PMID:28818686 |
|
NCBI chr 8:96,426,704...96,524,152
Ensembl chr 8:96,426,724...96,524,136
|
|
G |
Atrnl1 |
attractin like 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ATRNL1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:256,670,976...257,219,291
Ensembl chr 1:256,670,627...257,213,197
|
|
G |
Atxn1 |
ataxin 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ATXN1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:18,737,491...19,142,360
Ensembl chr17:18,737,533...19,142,360
|
|
G |
Aurka |
aurora kinase A |
decreases expression |
EXP ISO |
methyleugenol results in decreased expression of AURKA mRNA |
CTD |
PMID:26011634 PMID:32234424 |
|
NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390
|
|
G |
Aurkb |
aurora kinase B |
increases expression affects expression |
EXP |
methyleugenol results in increased expression of AURKB protein methyleugenol affects the expression of AURKB mRNA |
CTD |
PMID:23411599 PMID:26011634 |
|
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
|
|
G |
Azgp1 |
alpha-2-glycoprotein 1, zinc-binding |
decreases expression |
ISO |
methyleugenol results in decreased expression of AZGP1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:16,930,990...16,939,333
Ensembl chr12:16,931,024...16,939,091
|
|
G |
B3galt1 |
Beta-1,3-galactosyltransferase 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of B3GALT1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:52,253,413...52,826,508
Ensembl chr 3:52,253,618...52,825,313
|
|
G |
B3gnt3 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 |
increases expression |
ISO |
methyleugenol results in increased expression of B3GNT3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:18,401,405...18,410,821
Ensembl chr16:18,401,405...18,410,766
|
|
G |
B4galnt1 |
beta-1,4-N-acetyl-galactosaminyl transferase 1 |
increases expression |
ISO |
methyleugenol results in increased expression of B4GALNT1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:62,988,429...62,996,190
Ensembl chr 7:62,988,930...62,996,190
|
|
G |
Baat |
bile acid CoA:amino acid N-acyltransferase |
decreases expression |
ISO |
methyleugenol results in decreased expression of BAAT mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:63,851,668...63,860,641
Ensembl chr 5:63,850,705...63,860,685
|
|
G |
Babam2 |
BRISC and BRCA1 A complex member 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of BABAM2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:24,369,021...24,788,416
Ensembl chr 6:24,369,022...24,833,951
|
|
G |
Baiap2l2 |
BAR/IMD domain containing adaptor protein 2 like 2 |
increases expression |
ISO |
methyleugenol results in increased expression of BAIAP2L2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:110,824,370...110,850,702
Ensembl chr 7:110,824,375...110,850,702
|
|
G |
Bank1 |
B-cell scaffold protein with ankyrin repeats 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of BANK1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:224,530,475...224,800,420
Ensembl chr 2:224,530,475...224,800,405
|
|
G |
Batf3 |
basic leucine zipper ATF-like transcription factor 3 |
increases expression |
ISO |
methyleugenol results in increased expression of BATF3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:102,689,657...102,701,241
Ensembl chr13:102,689,657...102,701,139
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
methyleugenol results in increased expression of BAX mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbox1 |
gamma-butyrobetaine hydroxylase 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of BBOX1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:96,822,654...96,871,786
Ensembl chr 3:96,822,655...96,871,458
|
|
G |
Bbs9 |
Bardet-Biedl syndrome 9 |
decreases expression |
ISO |
methyleugenol results in decreased expression of BBS9 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:21,013,865...21,437,934
Ensembl chr 8:21,013,944...21,437,930
|
|
G |
Bcas3 |
BCAS3, microtubule associated cell migration factor |
decreases expression |
ISO |
methyleugenol results in decreased expression of BCAS3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:70,213,710...70,673,080
Ensembl chr10:70,214,098...70,673,080
|
|
G |
Bckdhb |
branched chain keto acid dehydrogenase E1 subunit beta |
decreases expression |
ISO |
methyleugenol results in decreased expression of BCKDHB mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:84,845,264...85,027,812
Ensembl chr 8:84,845,264...85,027,812
|
|
G |
Bcl2l15 |
Bcl2-like 15 |
increases expression |
ISO |
methyleugenol results in increased expression of BCL2L15 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:191,338,959...191,344,078
Ensembl chr 2:191,338,959...191,344,078
|
|
G |
Bdh1 |
3-hydroxybutyrate dehydrogenase 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of BDH1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:69,302,534...69,343,173
Ensembl chr11:69,302,534...69,337,671
|
|
G |
Bdkrb2 |
bradykinin receptor B2 |
increases expression |
ISO |
methyleugenol results in increased expression of BDKRB2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:124,472,317...124,502,497
Ensembl chr 6:124,472,566...124,502,497
|
|
G |
Bhlhe41 |
basic helix-loop-helix family, member e41 |
increases expression |
ISO |
methyleugenol results in increased expression of BHLHE41 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:178,834,264...178,838,618
Ensembl chr 4:178,834,271...178,838,468
|
|
G |
Bhmt |
betaine-homocysteine S-methyltransferase |
decreases expression |
ISO |
methyleugenol results in decreased expression of BHMT mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:24,859,871...24,879,449
Ensembl chr 2:24,859,873...24,879,742
|
|
G |
Bmerb1 |
bMERB domain containing 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of BMERB1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:1,779,834...1,946,586
Ensembl chr10:1,779,835...1,946,575
|
|
G |
Bmf |
Bcl2 modifying factor |
increases expression |
ISO |
methyleugenol results in increased expression of BMF mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:105,499,534...105,520,159
Ensembl chr 3:105,499,538...105,520,145
|
|
G |
Bmpr1b |
bone morphogenetic protein receptor type 1B |
decreases expression |
ISO |
methyleugenol results in decreased expression of BMPR1B mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:230,538,252...230,871,077
Ensembl chr 2:230,541,558...230,871,368
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
decreases expression |
EXP |
methyleugenol results in decreased expression of BRCA1 mRNA |
CTD |
PMID:21659616 PMID:26011634 |
|
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Brca2 |
BRCA2, DNA repair associated |
decreases expression |
EXP |
methyleugenol results in decreased expression of BRCA2 mRNA |
CTD |
PMID:26011634 |
|
NCBI chr12:59,492...103,789
Ensembl chr12:59,819...100,567
|
|
G |
Brcc3 |
BRCA1/BRCA2-containing complex subunit 3 |
affects expression |
EXP |
methyleugenol affects the expression of BRCC3 mRNA |
CTD |
PMID:26011634 |
|
NCBI chr 9:1,986,942...1,989,484
Ensembl chr 9:1,986,575...1,991,080
|
|
G |
Brinp1 |
BMP/retinoic acid inducible neural specific 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of BRINP1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:82,348,501...82,550,506
Ensembl chr 5:82,348,930...82,493,150
|
|
G |
Bsn |
bassoon (presynaptic cytomatrix protein) |
decreases expression |
ISO |
methyleugenol results in decreased expression of BSN mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:108,784,849...108,875,819
Ensembl chr 8:108,788,542...108,875,819
|
|
G |
Btbd16 |
BTB domain containing 16 |
decreases expression |
ISO |
methyleugenol results in decreased expression of BTBD16 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:185,334,971...185,389,518
Ensembl chr 1:185,335,725...185,389,517
|
|
G |
Btbd9 |
BTB domain containing 9 |
decreases expression |
ISO |
methyleugenol results in decreased expression of BTBD9 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr20:8,286,337...8,645,567
Ensembl chr20:8,288,711...8,643,960
|
|
G |
Bub1 |
BUB1 mitotic checkpoint serine/threonine kinase |
increases expression |
EXP |
methyleugenol results in increased expression of BUB1 mRNA |
CTD |
PMID:26011634 |
|
NCBI chr 3:115,020,254...115,051,650
Ensembl chr 3:115,020,254...115,051,650
|
|
G |
C13h1orf226 |
similar to human chromosome 1 open reading frame 226 |
decreases expression |
ISO |
methyleugenol results in decreased expression of C1ORF226 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:82,530,589...82,538,676
Ensembl chr13:82,530,577...82,820,949
|
|
G |
C1h11orf86 |
similar to human chromosome 11 open reading frame 86 |
decreases expression |
ISO |
methyleugenol results in decreased expression of C11ORF86 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:201,784,009...201,785,916
Ensembl chr 1:201,784,009...201,785,916
|
|
G |
C2cd4a |
C2 calcium-dependent domain containing 4A |
increases expression |
ISO |
methyleugenol results in increased expression of C2CD4A mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:68,467,017...68,469,781
Ensembl chr 8:68,466,664...68,470,031
|
|
G |
C4bpa |
complement component 4 binding protein, alpha |
decreases expression |
ISO |
methyleugenol results in decreased expression of C4BPA mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:42,075,715...42,111,205
Ensembl chr13:42,075,717...42,111,205
|
|
G |
C4bpb |
complement component 4 binding protein, beta |
decreases expression |
ISO |
methyleugenol results in decreased expression of C4BPB mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:42,120,798...42,131,515
Ensembl chr13:42,120,798...42,131,817
|
|
G |
C5 |
complement C5 |
decreases expression |
ISO |
methyleugenol results in decreased expression of C5 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994
|
|
G |
C6 |
complement C6 |
decreases expression |
ISO |
methyleugenol results in decreased expression of C6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:53,846,028...53,921,279
Ensembl chr 2:53,851,985...53,921,275
|
|
G |
C8a |
complement C8 alpha chain |
decreases expression |
ISO |
methyleugenol results in decreased expression of C8A mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:119,583,168...119,637,675
Ensembl chr 5:119,583,174...119,637,754
|
|
G |
C8b |
complement C8 beta chain |
decreases expression |
ISO |
methyleugenol results in decreased expression of C8B mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:119,535,009...119,572,565
Ensembl chr 5:119,535,146...119,572,565
|
|
G |
C8g |
complement C8 gamma chain |
decreases expression |
ISO |
methyleugenol results in decreased expression of C8G mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:8,320,503...8,322,087
Ensembl chr 3:8,305,920...8,323,495
|
|
G |
C8h11orf54 |
similar to human chromosome 11 open reading frame 54 |
decreases expression |
ISO |
methyleugenol results in decreased expression of C11ORF54 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:12,123,839...12,146,412
Ensembl chr 8:12,123,823...12,146,473
|
|
G |
C8h11orf65 |
similar to human chromosome 11 open reading frame 65 |
decreases expression |
ISO |
methyleugenol results in decreased expression of C11ORF65 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:53,796,033...53,825,277
Ensembl chr 8:53,796,366...53,824,748
|
|
G |
C9 |
complement C9 |
decreases expression |
ISO |
methyleugenol results in decreased expression of C9 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:55,573,094...55,621,345
Ensembl chr 2:55,572,992...55,621,338
|
|
G |
C9h6orf141 |
similar to human chromosome 6 open reading frame 141 |
increases expression |
ISO |
methyleugenol results in increased expression of C6ORF141 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:20,024,916...20,029,094
Ensembl chr 9:20,024,916...20,029,094
|
|
G |
Cacna1d |
calcium voltage-gated channel subunit alpha1 D |
decreases expression |
ISO |
methyleugenol results in decreased expression of CACNA1D mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:5,227,157...5,521,163
Ensembl chr16:5,228,306...5,668,215
|
|
G |
Cacna2d1 |
calcium voltage-gated channel auxiliary subunit alpha2delta 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CACNA2D1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:18,950,611...19,374,969
Ensembl chr 4:18,951,002...19,374,969
|
|
G |
Cacna2d3 |
calcium voltage-gated channel auxiliary subunit alpha2delta 3 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CACNA2D3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:4,098,439...4,912,498
Ensembl chr16:4,098,445...4,912,351
|
|
G |
Cacnb3 |
calcium voltage-gated channel auxiliary subunit beta 3 |
increases expression |
ISO |
methyleugenol results in increased expression of CACNB3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:129,784,799...129,797,074
Ensembl chr 7:129,783,674...129,797,074
|
|
G |
Cadm2 |
cell adhesion molecule 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CADM2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:4,548,367...5,525,420
Ensembl chr11:4,555,159...5,525,400
|
|
G |
Cadps2 |
calcium dependent secretion activator 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CADPS2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:51,780,415...52,309,641
Ensembl chr 4:51,781,053...52,309,829
|
|
G |
Calb2 |
calbindin 2 |
increases expression |
ISO |
methyleugenol results in increased expression of CALB2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:38,114,435...38,141,438
Ensembl chr19:38,114,424...38,141,438
|
|
G |
Calml4 |
calmodulin-like 4 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CALML4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:63,323,426...63,335,234
Ensembl chr 8:63,323,351...63,335,234
|
|
G |
Caln1 |
calneuron 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CALN1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:25,811,743...26,303,670
Ensembl chr12:25,819,628...26,303,344
|
|
G |
Camk1d |
calcium/calmodulin-dependent protein kinase ID |
decreases expression |
ISO |
methyleugenol results in decreased expression of CAMK1D mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:72,581,899...72,982,704
Ensembl chr17:72,581,979...72,980,556
|
|
G |
Camk4 |
calcium/calmodulin-dependent protein kinase IV |
decreases expression |
ISO |
methyleugenol results in decreased expression of CAMK4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr18:24,582,988...24,811,918
Ensembl chr18:24,585,269...24,802,487
|
|
G |
Car12 |
carbonic anhydrase 12 |
increases expression |
ISO |
methyleugenol results in increased expression of CA12 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:67,274,739...67,330,428
Ensembl chr 8:67,274,359...67,330,440
|
|
G |
Car3 |
carbonic anhydrase 3 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CA3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
|
|
G |
Car9 |
carbonic anhydrase 9 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CA9 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:57,763,234...57,769,838
Ensembl chr 5:57,763,206...57,769,838
|
|
G |
Carmil3 |
capping protein regulator and myosin 1 linker 3 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CARMIL3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:28,978,440...28,995,865
Ensembl chr15:28,979,007...28,996,225
|
|
G |
Casp16 |
caspase 16 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CASP16P mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:12,586,009...12,592,023
Ensembl chr10:12,586,729...12,589,053 Ensembl chr10:12,586,729...12,589,053
|
|
G |
Casp3 |
caspase 3 |
increases cleavage increases activity |
EXP ISO |
methyleugenol results in increased cleavage of CASP3 protein methyleugenol results in increased activity of CASP3 protein |
CTD |
PMID:26011634 PMID:28818686 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cat |
catalase |
decreases expression |
ISO |
methyleugenol results in decreased expression of CAT mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Catsper3 |
cation channel, sperm associated 3 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CATSPER3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:8,810,122...8,840,881
Ensembl chr17:8,815,561...8,840,864
|
|
G |
Catspere |
catsper channel auxiliary subunit epsilon |
decreases expression |
ISO |
methyleugenol results in decreased expression of CATSPERE mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:89,799,669...89,954,723
Ensembl chr13:89,819,244...89,950,979
|
|
G |
Cbarp |
CACN subunit beta associated regulatory protein |
decreases expression |
ISO |
methyleugenol results in decreased expression of CBARP mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:9,566,637...9,575,204
Ensembl chr 7:9,566,364...9,575,204
|
|
G |
Cbr3 |
carbonyl reductase 3 |
increases expression |
ISO |
methyleugenol results in increased expression of CBR3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:33,008,615...33,016,877
Ensembl chr11:33,008,615...33,016,875
|
|
G |
Cbx5 |
chromobox 5 |
increases expression |
EXP |
methyleugenol results in increased expression of CBX5 protein |
CTD |
PMID:23411599 |
|
NCBI chr 7:134,333,165...134,376,102
Ensembl chr 7:134,331,335...134,375,022
|
|
G |
Ccbe1 |
collagen and calcium binding EGF domains 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CCBE1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr18:59,579,851...59,823,977
Ensembl chr18:59,580,768...59,824,400
|
|
G |
Ccdc141 |
coiled-coil domain containing 141 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CCDC141 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:61,948,614...62,109,968
Ensembl chr 3:61,948,646...62,110,079
|
|
G |
Ccdc146 |
coiled-coil domain containing 146 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CCDC146 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:13,662,766...13,811,619
Ensembl chr 4:13,662,766...13,811,608
|
|
G |
Ccdc170 |
coiled-coil domain containing 170 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CCDC170 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:40,945,607...41,050,010
Ensembl chr 1:40,945,961...41,085,040
|
|
G |
Ccdc171 |
coiled-coil domain containing 171 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CCDC171 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:97,919,965...98,403,853
Ensembl chr 5:97,920,002...98,282,833
|
|
G |
Ccn2 |
cellular communication network factor 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CCN2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccnb1 |
cyclin B1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CCNB1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccng1 |
cyclin G1 |
increases expression |
ISO |
methyleugenol results in increased expression of CCNG1 mRNA |
CTD |
PMID:15618236 |
|
NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641
|
|
G |
Ccrl2 |
C-C motif chemokine receptor like 2 |
increases expression |
ISO |
methyleugenol results in increased expression of CCRL2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:111,034,279...111,036,914
Ensembl chr 8:111,034,279...111,036,664
|
|
G |
Ccser1 |
coiled-coil serine-rich protein 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CCSER1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:90,153,873...91,391,441
Ensembl chr 4:90,292,780...91,388,786
|
|
G |
Cd22 |
CD22 molecule |
increases expression |
ISO |
methyleugenol results in increased expression of CD22 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:86,116,376...86,132,782
Ensembl chr 1:86,117,459...86,132,322
|
|
G |
Cd44 |
CD44 molecule |
increases expression |
ISO |
methyleugenol results in increased expression of CD44 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
|
|
G |
Cd9 |
CD9 molecule |
increases expression |
ISO |
methyleugenol results in increased expression of CD9 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:158,256,328...158,289,136
Ensembl chr 4:158,256,328...158,289,222
|
|
G |
Cdc14a |
cell division cycle 14A |
decreases expression |
ISO |
methyleugenol results in decreased expression of CDC14A mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:204,225,540...204,380,927
Ensembl chr 2:204,225,540...204,380,927
|
|
G |
Cdc20b |
cell division cycle 20B |
decreases expression |
ISO |
methyleugenol results in decreased expression of CDC20B mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:44,688,349...44,738,056
|
|
G |
Cdca3 |
cell division cycle associated 3 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CDCA3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:157,634,775...157,638,799
Ensembl chr 4:157,634,928...157,638,799
|
|
G |
Cdh1 |
cadherin 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CDH1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdh12 |
cadherin 12 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CDH12 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:70,474,679...71,705,369
Ensembl chr 2:70,475,043...71,700,572
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
increases expression |
EXP |
methyleugenol results in increased expression of CDK1 protein |
CTD |
PMID:23411599 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdk14 |
cyclin-dependent kinase 14 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CDK14 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:28,666,416...29,258,865
Ensembl chr 4:28,666,843...29,258,861
|
|
G |
Cdk2ap2 |
cyclin-dependent kinase 2 associated protein 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CDK2AP2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:201,391,056...201,393,137
Ensembl chr 1:201,391,466...201,393,137
|
|
G |
Cdkal1 |
CDK5 regulatory subunit associated protein 1-like 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CDKAL1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:34,718,701...35,271,276
Ensembl chr17:34,718,687...35,407,524
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression increases phosphorylation |
ISO EXP |
methyleugenol results in increased expression of CDKN1A mRNA methyleugenol results in increased phosphorylation of CDKN1A protein methyleugenol results in increased expression of CDKN1A mRNA; methyleugenol results in increased expression of CDKN1A protein |
CTD |
PMID:15618236 PMID:23411599 PMID:26011634 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
increases expression decreases expression |
EXP |
methyleugenol results in increased expression of CDKN2A protein methyleugenol results in decreased expression of CDKN2A mRNA |
CTD |
PMID:23411599 PMID:26011634 |
|
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
|
|
G |
Cdo1 |
cysteine dioxygenase type 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CDO1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr18:39,432,473...39,447,253
Ensembl chr18:39,432,474...39,447,296
|
|
G |
Cdr2l |
cerebellar degeneration-related protein 2-like |
increases expression |
ISO |
methyleugenol results in increased expression of CDR2L mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:100,625,150...100,638,669
Ensembl chr10:100,624,607...100,638,666
|
|
G |
Ceacam1 |
CEA cell adhesion molecule 1 |
increases expression |
ISO |
methyleugenol results in increased expression of CEACAM1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:81,043,595...81,060,050
Ensembl chr 1:81,043,595...81,059,992
|
|
G |
Ceacam20 |
CEA cell adhesion molecule 20 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CEACAM20 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:79,622,077...79,643,782
Ensembl chr 1:79,622,077...79,643,782
|
|
G |
Cemip |
cell migration inducing hyaluronidase 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CEMIP mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:137,906,921...138,062,430
Ensembl chr 1:137,908,920...138,062,415
|
|
G |
Cenpa |
centromere protein A |
decreases expression |
ISO |
methyleugenol results in decreased expression of CENPA mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:25,700,142...25,711,767
Ensembl chr 6:25,700,142...25,711,675
|
|
G |
Cenpe |
centromere protein E |
decreases expression |
ISO |
methyleugenol results in decreased expression of CENPE mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:223,637,035...223,695,692
Ensembl chr 2:223,636,998...223,695,669
|
|
G |
Cep128 |
centrosomal protein 128 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CEP128 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:109,951,009...110,328,686
Ensembl chr 6:109,951,061...110,328,713
|
|
G |
Ces3a |
carboxylesterase 3a |
decreases expression |
ISO |
methyleugenol results in decreased expression of CES3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:32,992,386...33,000,562
|
|
G |
Cfap20dc |
CFAP20 domain containing |
decreases expression |
ISO |
methyleugenol results in decreased expression of CFAP20DC mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:16,231,248...16,476,978
Ensembl chr15:16,231,299...16,476,977
|
|
G |
Cfap52 |
cilia and flagella associated protein 52 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CFAP52 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:52,613,761...52,654,922
Ensembl chr10:52,613,762...52,654,934
|
|
G |
Cfb |
complement factor B |
decreases expression |
ISO |
methyleugenol results in decreased expression of CFB mRNA |
CTD |
PMID:32234424 |
|
NCBI chr20:3,970,643...3,976,510
Ensembl chr20:3,951,474...3,976,505
|
|
G |
Cfhr1 |
complement factor H-related 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CFHR1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:51,395,583...51,410,571
Ensembl chr13:51,369,211...51,410,592
|
|
G |
Cfhr4 |
complement factor H-related 4 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CFHR4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:51,422,592...51,491,476
Ensembl chr13:51,422,592...51,491,502
|
|
G |
Chek1 |
checkpoint kinase 1 |
affects expression |
EXP |
methyleugenol affects the expression of CHEK1 mRNA |
CTD |
PMID:26011634 |
|
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
|
|
G |
Chek2 |
checkpoint kinase 2 |
decreases expression |
EXP |
methyleugenol results in decreased expression of CHEK2 mRNA |
CTD |
PMID:26011634 |
|
NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
|
|
G |
Chn2 |
chimerin 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CHN2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:83,148,616...83,407,711
Ensembl chr 4:83,147,983...83,407,709
|
|
G |
Cideb |
cell death-inducing DFFA-like effector b |
decreases expression |
ISO |
methyleugenol results in decreased expression of CIDEB mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:29,252,208...29,256,482
Ensembl chr15:29,252,213...29,256,605
|
|
G |
Cish |
cytokine inducible SH2-containing protein |
decreases expression |
ISO |
methyleugenol results in decreased expression of CISH mRNA |
CTD |
PMID:15618236 |
|
NCBI chr 8:107,972,306...107,977,254
Ensembl chr 8:107,972,306...107,977,250
|
|
G |
Clcnka |
chloride voltage-gated channel Ka |
decreases expression |
ISO |
methyleugenol results in decreased expression of CLCNKA mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:153,691,208...153,706,295
Ensembl chr 5:153,691,209...153,706,148
|
|
G |
Cldn14 |
claudin 14 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CLDN14 mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr11:33,232,281...33,329,440
Ensembl chr11:33,232,220...33,329,171
|
|
G |
Cldn16 |
claudin 16 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CLDN16 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:74,290,298...74,309,588
Ensembl chr11:74,290,298...74,309,588
|
|
G |
Clrn3 |
clarin 3 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CLRN3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:190,319,025...190,334,648
Ensembl chr 1:190,319,026...190,334,648
|
|
G |
Clybl |
citramalyl-CoA lyase |
decreases expression |
ISO |
methyleugenol results in decreased expression of CLYBL mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:99,283,644...99,505,697
Ensembl chr15:99,283,650...99,505,695
|
|
G |
Cmss1 |
cms1 ribosomal small subunit homolog |
decreases expression |
ISO |
methyleugenol results in decreased expression of CMSS1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:42,934,390...43,232,624
Ensembl chr11:42,934,440...43,232,624
|
|
G |
Cnga1 |
cyclic nucleotide gated channel subunit alpha 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CNGA1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:35,566,947...35,605,065
Ensembl chr14:35,567,125...35,605,065
|
|
G |
Cnksr2 |
connector enhancer of kinase suppressor of Ras 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CNKSR2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr X:36,908,135...37,148,337
Ensembl chr X:36,907,850...37,150,555
|
|
G |
Cntn1 |
contactin 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CNTN1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:123,263,146...123,560,896
Ensembl chr 7:123,372,792...123,558,541
|
|
G |
Cntn5 |
contactin 5 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CNTN5 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:6,735,715...7,967,727
Ensembl chr 8:6,738,239...7,967,957
|
|
G |
Cobl |
cordon-bleu WH2 repeat protein |
decreases expression |
ISO |
methyleugenol results in decreased expression of COBL mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:86,828,137...87,060,682
Ensembl chr14:86,828,139...87,060,800
|
|
G |
Col18a1 |
collagen type XVIII alpha 1 chain |
decreases expression |
ISO |
methyleugenol results in decreased expression of COL18A1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr20:11,474,104...11,582,593
Ensembl chr20:11,474,104...11,582,593
|
|
G |
Col5a2 |
collagen type V alpha 2 chain |
decreases expression |
ISO |
methyleugenol results in decreased expression of COL5A2 mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr 9:47,448,741...47,598,134
Ensembl chr 9:47,448,736...47,598,154
|
|
G |
Col8a1 |
collagen type VIII alpha 1 chain |
decreases expression |
ISO |
methyleugenol results in decreased expression of COL8A1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:42,776,851...42,906,432
Ensembl chr11:42,777,628...42,906,424
|
|
G |
Commd1 |
copper metabolism domain containing 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of COMMD1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:96,880,463...96,984,494
Ensembl chr14:96,880,463...96,984,501
|
|
G |
Commd10 |
COMM domain containing 10 |
decreases expression |
ISO |
methyleugenol results in decreased expression of COMMD10 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr18:39,741,219...39,874,801
Ensembl chr18:39,741,298...39,874,903
|
|
G |
Cox6a2 |
cytochrome c oxidase subunit 6A2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of COX6A2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:182,788,528...182,790,746
Ensembl chr 1:182,788,528...182,789,274
|
|
G |
Cpa4 |
carboxypeptidase A4 |
increases expression |
ISO |
methyleugenol results in increased expression of CPA4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:59,188,284...59,212,255
Ensembl chr 4:59,188,284...59,212,255
|
|
G |
Cpa5 |
carboxypeptidase A5 |
increases expression |
ISO |
methyleugenol results in increased expression of CPA5 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:59,229,754...59,249,503
Ensembl chr 4:59,230,964...59,249,490
|
|
G |
Cpb2 |
carboxypeptidase B2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CPB2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:50,557,722...50,606,569
Ensembl chr15:50,557,717...50,606,556
|
|
G |
Cped1 |
cadherin-like and PC-esterase domain containing 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CPED1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:50,516,712...50,789,651
Ensembl chr 4:50,516,819...50,788,674
|
|
G |
Cplx1 |
complexin 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CPLX1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:1,184,677...1,216,392
|
|
G |
Cpn1 |
carboxypeptidase N subunit 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CPN1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:242,844,575...242,873,465
Ensembl chr 1:242,844,212...242,873,465
|
|
G |
Cpne2 |
copine 2 |
increases expression |
ISO |
methyleugenol results in increased expression of CPNE2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:10,434,277...10,472,146
Ensembl chr19:10,434,277...10,471,820
|
|
G |
Cpne4 |
copine 4 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CPNE4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:105,177,376...105,653,075
Ensembl chr 8:105,177,376...105,653,068
|
|
G |
Cpne6 |
copine 6 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CPNE6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:28,998,293...29,005,044
Ensembl chr15:28,998,293...29,005,044
|
|
G |
Cpq |
carboxypeptidase Q |
decreases expression |
ISO |
methyleugenol results in decreased expression of CPQ mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:64,264,025...64,830,867
Ensembl chr 7:64,264,081...64,724,546
|
|
G |
Cps1 |
carbamoyl-phosphate synthase 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CPS1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:68,614,153...68,737,037
Ensembl chr 9:68,614,153...68,737,033
|
|
G |
Cpvl |
carboxypeptidase, vitellogenic-like |
decreases expression |
ISO |
methyleugenol results in decreased expression of CPVL mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:82,981,421...83,091,730
Ensembl chr 4:82,981,422...83,085,655
|
|
G |
Crb1 |
crumbs cell polarity complex component 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CRB1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:50,801,484...50,989,261
Ensembl chr13:50,800,959...50,989,261
|
|
G |
Creld2 |
cysteine-rich with EGF-like domains 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CRELD2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:119,909,626...119,916,556
Ensembl chr 7:119,909,633...119,916,543
|
|
G |
Crp |
C-reactive protein |
decreases expression |
ISO |
methyleugenol results in decreased expression of CRP mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
|
|
G |
Crppa |
CDP-L-ribitol pyrophosphorylase A |
decreases expression |
ISO |
methyleugenol results in decreased expression of CRPPA mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:53,120,264...53,397,030
Ensembl chr 6:53,121,438...53,397,028
|
|
G |
Crybg2 |
crystallin beta-gamma domain containing 2 |
increases expression |
ISO |
methyleugenol results in increased expression of CRYBG2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:146,286,406...146,318,417
Ensembl chr 5:146,286,925...146,323,666
|
|
G |
Cth |
cystathionine gamma-lyase |
decreases expression |
ISO |
methyleugenol results in decreased expression of CTH mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
|
|
G |
Ctnna3 |
catenin alpha 3 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CTNNA3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr20:23,614,469...25,200,026
Ensembl chr20:23,623,560...25,199,978
|
|
G |
Ctnnb1 |
catenin beta 1 |
increases mutagenesis |
ISO |
methyleugenol results in increased mutagenesis of CTNNB1 gene |
CTD |
PMID:10467420 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Ctxn1 |
cortexin 1 |
increases expression |
ISO |
methyleugenol results in increased expression of CTXN1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:2,610,465...2,612,076
|
|
G |
Cux2 |
cut-like homeobox 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CUX2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:34,507,723...34,707,581
Ensembl chr12:34,520,959...34,705,806
|
|
G |
Cx3cr1 |
C-X3-C motif chemokine receptor 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CX3CR1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:119,785,726...119,799,431
Ensembl chr 8:119,782,595...119,800,014
|
|
G |
Cxcl13 |
C-X-C motif chemokine ligand 13 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CXCL13 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:13,608,894...13,613,965
Ensembl chr14:13,608,902...13,613,933
|
|
G |
Cxxc4 |
CXXC finger protein 4 |
increases expression |
ISO |
methyleugenol results in increased expression of CXXC4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:222,664,148...222,689,365
Ensembl chr 2:222,664,771...222,689,365
|
|
G |
Cyba |
cytochrome b-245 alpha chain |
decreases expression |
ISO |
methyleugenol results in decreased expression of CYBA mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression |
ISO |
methyleugenol results in increased expression of CYP1A1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases expression |
ISO |
methyleugenol results in increased expression of CYP1A2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
increases expression |
ISO |
methyleugenol results in increased expression of CYP1B1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp2a1 |
cytochrome P450, family 2, subfamily a, polypeptide 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CYP2A13 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:82,231,611...82,244,887
Ensembl chr 1:82,231,611...82,244,887
|
|
G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CYP2A7 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:82,171,914...82,179,980
Ensembl chr 1:82,169,949...82,179,979
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CYP2B6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2c6 |
cytochrome P450, family 2, subfamily C, polypeptide 6 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CYP2C19 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Cyp2c79 |
cytochrome P450, family 2, subfamily c, polypeptide 79 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CYP2C8 mRNA |
CTD |
PMID:32234424 |
|
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CYP2D6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CYP2E1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp46a1 |
cytochrome P450, family 46, subfamily a, polypeptide 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CYP46A1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:127,247,543...127,274,765
Ensembl chr 6:127,243,315...127,274,760
|
|
G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CYP4A22 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:129,123,323...129,137,464
Ensembl chr 5:129,123,336...129,137,464
|
|
G |
Cyp4b1 |
cytochrome P450, family 4, subfamily b, polypeptide 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CYP4B1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:129,139,019...129,176,860
Ensembl chr 5:129,139,038...129,156,348
|
|
G |
Cyp4x1 |
cytochrome P450, family 4, subfamily x, polypeptide 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CYP4X1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:128,651,681...128,683,338
Ensembl chr 5:128,651,776...128,682,779
|
|
G |
Cyp7a1 |
cytochrome P450 family 7 subfamily A member 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CYP7A1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
|
|
G |
Cyp7b1 |
cytochrome P450 family 7 subfamily B member 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CYP7B1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:100,502,791...100,669,713
Ensembl chr 2:100,502,791...100,669,698
|
|
G |
Cyp8b1 |
cytochrome P450 family 8 subfamily B member 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of CYP8B1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
|
|
G |
Dab1 |
DAB adaptor protein 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of DAB1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:118,392,953...119,513,625
Ensembl chr 5:119,140,533...119,510,552
|
|
G |
Dach2 |
dachshund family transcription factor 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of DACH2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr X:78,718,963...79,018,023
Ensembl chr X:78,451,593...79,017,592
|
|
G |
Dao |
D-amino-acid oxidase |
decreases expression |
ISO |
methyleugenol results in decreased expression of DAO mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:42,592,342...42,613,046
Ensembl chr12:42,592,343...42,612,741
|
|
G |
Dbndd1 |
dysbindin domain containing 1 |
increases expression |
ISO |
methyleugenol results in increased expression of DBNDD1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:51,539,154...51,548,441
Ensembl chr19:51,539,148...51,548,444
|
|
G |
Dcaf11 |
DDB1 and CUL4 associated factor 11 |
decreases expression |
ISO |
methyleugenol results in decreased expression of DCAF11 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:29,046,744...29,057,450
Ensembl chr15:29,046,826...29,057,669
|
|
G |
Dcdc1-ps1 |
doublecortin domain containing 1, pseudogene 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of DCDC1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:92,486,054...92,896,696
Ensembl chr 3:92,718,047...92,896,542
|
|
G |
Dchs2 |
dachsous cadherin-related 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of DCHS2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:168,478,298...168,685,802
Ensembl chr 2:168,478,826...168,682,732
|
|
G |
Dcxr |
dicarbonyl and L-xylulose reductase |
decreases expression |
ISO |
methyleugenol results in decreased expression of DCXR mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:106,006,404...106,008,293
|
|
G |
Ddc |
dopa decarboxylase |
decreases expression |
ISO |
methyleugenol results in decreased expression of DDC mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
|
|
G |
Ddr2 |
discoidin domain receptor tyrosine kinase 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of DDR2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:82,193,623...82,318,229
Ensembl chr13:82,195,463...82,317,363
|
|
G |
Ddt |
D-dopachrome tautomerase |
decreases expression |
ISO |
methyleugenol results in decreased expression of DDT mRNA |
CTD |
PMID:32234424 |
|
NCBI chr20:12,884,216...12,886,687
Ensembl chr20:12,884,243...12,888,482
|
|
G |
Defb1 |
defensin beta 1 |
increases expression |
ISO |
methyleugenol results in increased expression of DEFB1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:70,298,862...70,313,604
Ensembl chr16:70,298,863...70,313,604
|
|
G |
Dennd1a |
DENN domain containing 1A |
decreases expression |
ISO |
methyleugenol results in decreased expression of DENND1A mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:21,564,749...22,052,057
Ensembl chr 3:21,564,749...22,052,062
|
|
G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of DGAT1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:108,223,860...108,235,413
Ensembl chr 7:108,218,524...108,234,299
|
|
G |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of DGAT2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:153,454,078...153,484,432
Ensembl chr 1:153,454,080...153,484,428
|
|
G |
Dhrs2 |
dehydrogenase/reductase 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of DHRS2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:28,688,881...28,703,646
Ensembl chr15:28,688,940...28,703,644
|
|
G |
Dhrs9 |
dehydrogenase/reductase 9 |
increases expression |
ISO |
methyleugenol results in increased expression of DHRS9 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:54,147,834...54,170,052
Ensembl chr 3:54,147,803...54,220,241
|
|
G |
Dhrsx |
dehydrogenase/reductase X-linked |
decreases expression |
ISO |
methyleugenol results in decreased expression of DHRSX mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:16,299,768...16,304,553
Ensembl chr12:16,299,808...16,304,552
|
|
G |
Dhtkd1 |
dehydrogenase E1 and transketolase domain containing 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of DHTKD1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:72,355,201...72,406,725
Ensembl chr17:72,355,201...72,406,723
|
|
G |
Diaph2 |
diaphanous-related formin 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of DIAPH2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr X:92,395,189...93,234,521
Ensembl chr X:92,395,251...93,229,869
|
|
G |
Dio1 |
iodothyronine deiodinase 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of DIO1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:122,074,285...122,090,983
Ensembl chr 5:122,074,279...122,090,970
|
|
G |
Dip2c |
disco-interacting protein 2 homolog C |
decreases expression |
ISO |
methyleugenol results in decreased expression of DIP2C mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:60,647,346...61,032,467
Ensembl chr17:60,649,065...61,032,305
|
|
G |
Diras3 |
DIRAS family GTPase 3 |
decreases expression |
ISO |
methyleugenol results in decreased expression of DIRAS3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:130,524,972...130,526,186
Ensembl chr 6:130,524,742...130,530,825
|
|
G |
Disc1 |
DISC1 scaffold protein |
decreases expression |
ISO |
methyleugenol results in decreased expression of DISC1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:53,014,201...53,223,617
Ensembl chr19:53,014,616...53,219,778
|
|
G |
Dlg2 |
discs large MAGUK scaffold protein 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of DLG2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:144,451,653...146,503,949
Ensembl chr 1:144,451,472...146,499,475
|
|
G |
Dmgdh |
dimethylglycine dehydrogenase |
decreases expression |
ISO |
methyleugenol results in decreased expression of DMGDH mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:24,912,600...24,987,533
Ensembl chr 2:24,912,578...24,987,528
|
|
G |
Dnah1 |
dynein, axonemal, heavy chain 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of DNAH1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:6,455,514...6,517,103
Ensembl chr16:6,456,002...6,518,350
|
|
G |
Dnah11 |
dynein, axonemal, heavy chain 11 |
decreases expression |
ISO |
methyleugenol results in decreased expression of DNAH11 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:138,839,175...139,155,554
Ensembl chr 6:138,839,177...139,155,536
|
|
G |
Dnah12 |
dynein, axonemal, heavy chain 12 |
decreases expression |
ISO |
methyleugenol results in decreased expression of DNAH12 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:1,936,354...2,092,663
Ensembl chr16:1,937,817...2,092,664
|
|
G |
Dnah5 |
dynein, axonemal, heavy chain 5 |
decreases expression |
ISO |
methyleugenol results in decreased expression of DNAH5 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:78,937,788...79,255,551
Ensembl chr 2:78,937,800...79,254,890
|
|
G |
Dnah6 |
dynein, axonemal, heavy chain 6 |
decreases expression |
ISO |
methyleugenol results in decreased expression of DNAH6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:105,064,123...105,284,361
Ensembl chr 4:105,064,125...105,284,376
|
|
G |
Dnase2 |
deoxyribonuclease 2, lysosomal |
increases expression |
ISO |
methyleugenol results in increased expression of DNASE2A mRNA |
CTD |
PMID:15618236 |
|
NCBI chr19:23,244,656...23,247,376
Ensembl chr19:23,244,664...23,247,376
|
|
G |
Dock1 |
dedicator of cyto-kinesis 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of DOCK1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:189,467,143...189,983,777
Ensembl chr 1:189,467,143...189,983,768
|
|
G |
Dock8 |
dedicator of cytokinesis 8 |
decreases expression |
ISO |
methyleugenol results in decreased expression of DOCK8 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:222,649,309...222,842,474
Ensembl chr 1:222,649,309...222,842,474
|
|
G |
Dpf3 |
double PHD fingers 3 |
decreases expression |
ISO |
methyleugenol results in decreased expression of DPF3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:102,841,403...103,125,558
Ensembl chr 6:102,846,029...103,125,493
|
|
G |
Dpyd |
dihydropyrimidine dehydrogenase |
decreases expression |
ISO |
methyleugenol results in decreased expression of DPYD mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982
|
|
G |
Dpys |
dihydropyrimidinase |
decreases expression |
ISO |
methyleugenol results in decreased expression of DPYS mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:70,822,648...70,929,255
Ensembl chr 7:70,835,789...70,929,231
|
|
G |
Draxin |
dorsal inhibitory axon guidance protein |
increases expression |
ISO |
methyleugenol results in increased expression of DRAXIN mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:158,530,149...158,563,457
Ensembl chr 5:158,530,342...158,564,483
|
|
G |
Drgx |
dorsal root ganglia homeobox |
decreases expression |
ISO |
methyleugenol results in decreased expression of DRGX mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:7,854,849...7,884,404
Ensembl chr16:7,854,849...7,900,600
|
|
G |
Dsc2 |
desmocollin 2 |
increases expression |
ISO |
methyleugenol results in increased expression of DSC2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr18:11,450,392...11,482,476
Ensembl chr18:11,450,390...11,482,392
|
|
G |
Dusp15 |
dual specificity phosphatase 15 |
increases expression |
ISO |
methyleugenol results in increased expression of DUSP15 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:141,408,495...141,419,137
Ensembl chr 3:141,408,498...141,418,999
|
|
G |
Dusp9 |
dual specificity phosphatase 9 |
decreases expression |
ISO |
methyleugenol results in decreased expression of DUSP9 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr X:151,351,897...151,355,822
Ensembl chr X:151,351,897...151,355,821
|
|
G |
Dync2h1 |
dynein cytoplasmic 2 heavy chain 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of DYNC2H1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:4,189,067...4,412,183
Ensembl chr 8:4,189,257...4,412,183
|
|
G |
Ebf1 |
EBF transcription factor 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of EBF1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:29,095,858...29,489,142
Ensembl chr10:29,099,933...29,487,665
|
|
G |
Ecm2 |
extracellular matrix protein 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ECM2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:15,120,194...15,152,536
Ensembl chr17:15,120,196...15,152,516
|
|
G |
Edil3 |
EGF like repeats and discoidin domains 3 |
decreases expression |
ISO |
methyleugenol results in decreased expression of EDIL3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:19,890,396...20,405,028
Ensembl chr 2:19,890,373...20,405,008
|
|
G |
Eef1a2 |
eukaryotic translation elongation factor 1 alpha 2 |
increases expression |
ISO |
methyleugenol results in increased expression of EEF1A2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:168,265,893...168,275,071
Ensembl chr 3:168,195,357...168,275,071
|
|
G |
Efcab11 |
EF-hand calcium binding domain 11 |
decreases expression |
ISO |
methyleugenol results in decreased expression of EFCAB11 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:119,008,908...119,162,994
Ensembl chr 6:119,008,919...119,162,046
|
|
G |
Efcab6 |
EF-hand calcium binding domain 6 |
decreases expression |
ISO |
methyleugenol results in decreased expression of EFCAB6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:115,018,971...115,200,121
Ensembl chr 7:115,019,010...115,206,092
|
|
G |
Egfr |
epidermal growth factor receptor |
decreases expression |
ISO |
methyleugenol results in decreased expression of EGFR protein |
CTD |
PMID:15618236 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Egr1 |
early growth response 1 |
increases expression |
ISO |
methyleugenol results in increased expression of EGR1 mRNA |
CTD |
PMID:15618236 |
|
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Ehbp1l1 |
EH domain binding protein 1-like 1 |
increases expression |
ISO |
methyleugenol results in increased expression of EHBP1L1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:202,994,115...203,014,320
Ensembl chr 1:202,994,118...203,014,270
|
|
G |
Ehhadh |
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase |
decreases expression |
ISO |
methyleugenol results in decreased expression of EHHADH mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:79,241,927...79,275,173
Ensembl chr11:79,241,938...79,275,188
|
|
G |
Elapor1 |
endosome-lysosome associated apoptosis and autophagy regulator 1 |
increases expression |
ISO |
methyleugenol results in increased expression of ELAPOR1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:196,089,199...196,169,055
Ensembl chr 2:196,091,646...196,168,716
|
|
G |
Elmo1 |
engulfment and cell motility 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ELMO1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:44,286,495...44,822,668
Ensembl chr17:44,286,485...44,822,788
|
|
G |
Elp4 |
elongator acetyltransferase complex subunit 4 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ELP4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:92,162,271...92,385,251
Ensembl chr 3:92,162,280...92,385,243
|
|
G |
Eml6 |
EMAP like 6 |
decreases expression |
ISO |
methyleugenol results in decreased expression of EML6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:103,471,537...103,806,120
Ensembl chr14:103,476,372...103,805,849
|
|
G |
Enox1 |
ecto-NOX disulfide-thiol exchanger 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ENOX1 mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr15:52,517,833...53,079,752
Ensembl chr15:52,515,178...53,079,749
|
|
G |
Enpp3 |
ectonucleotide pyrophosphatase/phosphodiesterase 3 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ENPP3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:20,563,700...20,635,044
Ensembl chr 1:20,563,697...20,635,041
|
|
G |
Enpp6 |
ectonucleotide pyrophosphatase/phosphodiesterase 6 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ENPP6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:45,165,883...45,294,126
Ensembl chr16:45,169,178...45,294,077
|
|
G |
Entpd8 |
ectonucleoside triphosphate diphosphohydrolase 8 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ENTPD8 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:7,885,277...7,895,517
Ensembl chr 3:7,889,909...7,895,296
|
|
G |
Ephx2 |
epoxide hydrolase 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of EPHX2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615
|
|
G |
Epm2a |
EPM2A glucan phosphatase, laforin |
decreases expression |
ISO |
methyleugenol results in decreased expression of EPM2A mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:5,727,111...5,845,338
Ensembl chr 1:5,727,066...5,920,555
|
|
G |
Eps8l3 |
EPS8 like 3 |
increases expression |
ISO |
methyleugenol results in increased expression of EPS8L3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:195,514,692...195,528,085
Ensembl chr 2:195,514,692...195,528,085
|
|
G |
Erbb4 |
erb-b2 receptor tyrosine kinase 4 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ERBB4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:69,523,733...70,596,743
Ensembl chr 9:69,531,481...70,596,595
|
|
G |
Ereg |
epiregulin |
increases expression |
ISO |
methyleugenol results in increased expression of EREG mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:17,027,287...17,041,062
Ensembl chr14:17,027,287...17,041,062
|
|
G |
Erich4 |
glutamate-rich 4 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ERICH4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:81,123,556...81,125,296
Ensembl chr 1:81,123,556...81,125,296
|
|
G |
Erln |
endoregulin |
increases expression |
ISO |
methyleugenol results in increased expression of ERLN mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:101,144,577...101,147,160
|
|
G |
Erp27 |
endoplasmic reticulum protein 27 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ERP27 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:169,804,656...169,821,660
Ensembl chr 4:169,804,658...169,821,660
|
|
G |
Esam |
endothelial cell adhesion molecule |
increases expression |
ISO |
methyleugenol results in increased expression of ESAM mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:37,238,228...37,249,217
Ensembl chr 8:37,238,287...37,249,215
|
|
G |
Esco1 |
establishment of sister chromatid cohesion N-acetyltransferase 1 |
decreases expression |
EXP |
methyleugenol results in decreased expression of ESCO1 mRNA |
CTD |
PMID:26011634 |
|
NCBI chr18:1,630,560...1,686,803
Ensembl chr18:1,631,954...1,686,942
|
|
G |
Espl1 |
extra spindle pole bodies like 1, separase |
decreases expression |
ISO |
methyleugenol results in decreased expression of ESPL1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:133,424,027...133,450,984
Ensembl chr 7:133,424,130...133,450,984
|
|
G |
Espn |
espin |
decreases expression |
ISO |
methyleugenol results in decreased expression of ESPN mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:162,626,560...162,660,439
Ensembl chr 5:162,626,560...162,660,256
|
|
G |
Esrrg |
estrogen-related receptor gamma |
decreases expression |
ISO |
methyleugenol results in decreased expression of ESRRG mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:99,167,656...99,788,016
Ensembl chr13:99,564,669...99,783,397
|
|
G |
Etnk2 |
ethanolamine kinase 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of ETNK2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:44,811,012...44,829,052
Ensembl chr13:44,811,015...44,829,037
|
|
G |
Eva1b |
eva-1 homolog B |
increases expression |
ISO |
methyleugenol results in increased expression of EVA1B mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:138,427,088...138,429,602
Ensembl chr 5:138,427,151...138,432,433
|
|
G |
Exoc3l4 |
exocyst complex component 3-like 4 |
decreases expression |
ISO |
methyleugenol results in decreased expression of EXOC3L4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:130,452,680...130,466,684
Ensembl chr 6:130,452,661...130,466,683
|
|
G |
Exoc4 |
exocyst complex component 4 |
decreases expression |
ISO |
methyleugenol results in decreased expression of EXOC4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:61,807,706...62,584,316
Ensembl chr 4:61,807,761...62,585,723
|
|
G |
Eya2 |
EYA transcriptional coactivator and phosphatase 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of EYA2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:154,335,598...154,519,006
Ensembl chr 3:154,335,400...154,518,793
|
|
G |
Eya4 |
EYA transcriptional coactivator and phosphatase 4 |
decreases expression |
ISO |
methyleugenol results in decreased expression of EYA4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:22,172,275...22,415,978
Ensembl chr 1:22,172,275...22,415,976
|
|
G |
F11 |
coagulation factor XI |
decreases expression |
ISO |
methyleugenol results in decreased expression of F11 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:46,987,988...47,009,015
Ensembl chr16:46,986,107...47,008,437
|
|
G |
F12 |
coagulation factor XII |
decreases expression |
ISO |
methyleugenol results in decreased expression of F12 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:9,207,683...9,215,530
Ensembl chr17:9,207,683...9,215,530
|
|
G |
F2rl2 |
coagulation factor II (thrombin) receptor-like 2 |
increases expression |
ISO |
methyleugenol results in increased expression of F2RL2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:26,972,054...26,977,098
Ensembl chr 2:26,972,054...26,977,098
|
|
G |
F7 |
coagulation factor VII |
decreases expression |
ISO |
methyleugenol results in decreased expression of F7 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:76,489,775...76,500,636
Ensembl chr16:76,489,717...76,500,610
|
|
G |
F9 |
coagulation factor IX |
decreases expression |
ISO |
methyleugenol results in decreased expression of F9 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr X:138,352,334...138,396,835
Ensembl chr X:138,352,298...138,396,835
|
|
G |
Fabp1 |
fatty acid binding protein 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of FABP1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788
|
|
G |
Fam151a |
family with sequence similarity 151, member A |
decreases expression |
ISO |
methyleugenol results in decreased expression of FAM151A mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:121,514,804...121,527,555
Ensembl chr 5:121,514,804...121,527,555
|
|
G |
Fam167a |
family with sequence similarity 167, member A |
increases expression |
ISO |
methyleugenol results in increased expression of FAM167A mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:37,685,221...37,715,472
Ensembl chr15:37,700,919...37,715,469
|
|
G |
Fam171a2 |
family with sequence similarity 171, member A2 |
increases expression |
ISO |
methyleugenol results in increased expression of FAM171A2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:87,393,888...87,404,051
Ensembl chr10:87,394,007...87,404,053
|
|
G |
Fam78b |
family with sequence similarity 78, member B |
decreases expression |
ISO |
methyleugenol results in decreased expression of FAM78B mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:79,162,393...79,250,958
Ensembl chr13:79,162,228...79,250,500
|
|
G |
Fam83d |
family with sequence similarity 83, member D |
decreases expression |
ISO |
methyleugenol results in decreased expression of FAM83D mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:147,421,941...147,441,211
Ensembl chr 3:147,421,908...147,441,192
|
|
G |
Fank1 |
fibronectin type III and ankyrin repeat domains 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of FANK1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:188,577,512...188,685,501
Ensembl chr 1:188,577,575...188,685,504
|
|
G |
Far1 |
fatty acyl CoA reductase 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of FAR1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:167,644,622...167,705,868
Ensembl chr 1:167,644,677...167,705,730
|
|
G |
Fars2 |
phenylalanyl-tRNA synthetase 2, mitochondrial |
decreases expression |
ISO |
methyleugenol results in decreased expression of FARS2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:28,319,215...28,746,217
Ensembl chr17:28,319,280...28,746,337
|
|
G |
Fasn |
fatty acid synthase |
decreases expression |
ISO |
methyleugenol results in decreased expression of FASN mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fat3 |
FAT atypical cadherin 3 |
decreases expression |
ISO |
methyleugenol results in decreased expression of FAT3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:12,691,470...13,274,336
Ensembl chr 8:12,694,019...13,273,135
|
|
G |
Fblim1 |
filamin binding LIM protein 1 |
increases expression |
ISO |
methyleugenol results in increased expression of FBLIM1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:153,883,945...153,915,524
Ensembl chr 5:153,883,960...153,913,757
|
|
G |
Fbp1 |
fructose-bisphosphatase 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of FBP1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:2,207,271...2,230,076
Ensembl chr17:2,208,031...2,230,071
|
|
G |
Fbxl17 |
F-box and leucine-rich repeat protein 17 |
decreases expression |
ISO |
methyleugenol results in decreased expression of FBXL17 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:102,780,573...103,206,978
Ensembl chr 9:102,782,440...103,208,950
|
|
G |
Fbxo15 |
F-box protein 15 |
decreases expression |
ISO |
methyleugenol results in decreased expression of FBXO15 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr18:78,319,577...78,634,695
Ensembl chr18:78,319,534...78,390,765
|
|
G |
Fbxo43 |
F-box protein 43 |
decreases expression |
ISO |
methyleugenol results in decreased expression of FBXO43 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:67,333,161...67,346,751
Ensembl chr 7:67,333,162...67,346,751
|
|
G |
Fer |
FER tyrosine kinase |
decreases expression |
ISO |
methyleugenol results in decreased expression of FER mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:103,520,452...103,827,364
Ensembl chr 9:103,520,493...103,821,451
|
|
G |
Fer1l6 |
fer-1-like family member 6 |
decreases expression |
ISO |
methyleugenol results in decreased expression of FER1L6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:90,093,567...90,216,907
Ensembl chr 7:90,061,924...90,215,214
|
|
G |
Fetub |
fetuin B |
decreases expression |
ISO |
methyleugenol results in decreased expression of FETUB mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:78,082,158...78,093,022
Ensembl chr11:78,082,156...78,095,135
|
|
G |
Fga |
fibrinogen alpha chain |
decreases expression |
ISO |
methyleugenol results in decreased expression of FGA mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:168,374,120...168,381,523
Ensembl chr 2:168,374,120...168,381,528
|
|
G |
Fgb |
fibrinogen beta chain |
decreases expression |
ISO |
methyleugenol results in decreased expression of FGB mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:168,394,901...168,402,863
Ensembl chr 2:168,394,916...168,405,979
|
|
G |
Fgd5 |
FYVE, RhoGEF and PH domain containing 5 |
decreases expression |
ISO |
methyleugenol results in decreased expression of FGD5 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:124,497,061...124,594,564
Ensembl chr 4:124,497,068...124,594,563
|
|
G |
Fgf12 |
fibroblast growth factor 12 |
decreases expression |
ISO |
methyleugenol results in decreased expression of FGF12 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:71,997,151...72,564,757
Ensembl chr11:71,997,099...72,562,607
|
|
G |
Fgf13 |
fibroblast growth factor 13 |
decreases expression |
ISO |
methyleugenol results in decreased expression of FGF13 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr X:137,276,498...137,800,056
Ensembl chr X:137,276,511...137,800,391
|
|
G |
Fgf14 |
fibroblast growth factor 14 |
decreases expression |
ISO |
methyleugenol results in decreased expression of FGF14 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:101,045,033...101,679,888
Ensembl chr15:101,045,036...101,679,900
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of FGFR2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
|
|
G |
Fggy |
FGGY carbohydrate kinase domain containing |
decreases expression |
ISO |
methyleugenol results in decreased expression of FGGY mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:110,398,866...110,786,019
Ensembl chr 5:110,398,863...110,786,017
|
|
G |
Fgl2 |
fibrinogen-like 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of FGL2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:13,710,566...13,716,207
Ensembl chr 4:13,710,575...13,716,207
|
|
G |
Fhit |
fragile histidine triad diadenosine triphosphatase |
decreases expression |
ISO |
methyleugenol results in decreased expression of FHIT mRNA; methyleugenol results in decreased expression of FHIT protein |
CTD |
PMID:15618236 PMID:32234424 PMID:35690182 |
|
NCBI chr15:13,935,029...15,442,620
Ensembl chr15:13,934,995...15,442,340
|
|
G |
Fhod3 |
formin homology 2 domain containing 3 |
decreases expression |
ISO |
methyleugenol results in decreased expression of FHOD3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr18:15,993,079...16,425,796
Ensembl chr18:15,993,324...16,425,796
|
|
G |
Filip1 |
filamin A interacting protein 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of FILIP1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:80,761,283...80,956,556
Ensembl chr 8:80,764,604...80,922,549
|
|
G |
Filip1l |
filamin A interacting protein 1-like |
increases expression |
ISO |
methyleugenol results in increased expression of FILIP1L mRNA |
CTD |
PMID:32234424 |
|
NCBI chr11:42,937,353...43,177,085
Ensembl chr11:42,940,467...43,177,415
|
|
G |
Fitm1 |
fat storage-inducing transmembrane protein 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of FITM1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:29,064,746...29,066,015
Ensembl chr15:29,064,707...29,066,015
|
|
G |
Flrt2 |
fibronectin leucine rich transmembrane protein 2 |
increases expression |
ISO |
methyleugenol results in increased expression of FLRT2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:114,777,547...114,872,688
Ensembl chr 6:114,777,599...114,872,785
|
|
G |
Fmo1 |
flavin containing dimethylaniline monoxygenase 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of FMO1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:75,182,184...75,214,439
Ensembl chr13:75,182,176...75,214,647
|
|
G |
Fmo5 |
flavin containing dimethylaniline monoxygenase 5 |
decreases expression |
ISO |
methyleugenol results in decreased expression of FMO5 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:185,197,184...185,249,699
Ensembl chr 2:185,222,204...185,249,693
|
|
G |
Fosl1 |
FOS like 1, AP-1 transcription factor subunit |
increases expression |
ISO |
methyleugenol results in increased expression of FOSL1 mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
|
|
G |
Foxa3 |
forkhead box A3 |
increases expression |
ISO |
methyleugenol results in increased expression of FOXA3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:78,662,067...78,672,321
Ensembl chr 1:78,662,431...78,672,155
|
|
G |
Fras1 |
Fraser extracellular matrix complex subunit 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of FRAS1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:12,791,407...13,200,862
Ensembl chr14:12,793,599...13,200,726
|
|
G |
Frmpd2 |
FERM and PDZ domain containing 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of FRMPD2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:8,757,642...8,877,307
Ensembl chr16:8,757,705...8,877,303
|
|
G |
Fst |
follistatin |
increases expression |
ISO |
methyleugenol results in increased expression of FST mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:46,123,260...46,130,584
Ensembl chr 2:46,123,439...46,130,571
|
|
G |
Fto |
FTO, alpha-ketoglutarate dependent dioxygenase |
decreases expression |
ISO |
methyleugenol results in decreased expression of FTO mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:15,284,898...15,692,142
Ensembl chr19:15,349,696...15,692,083
|
|
G |
Fuom |
fucose mutarotase |
decreases expression |
ISO |
methyleugenol results in decreased expression of FUOM mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:194,888,535...194,893,046
Ensembl chr 1:194,886,709...194,893,046
|
|
G |
Fut4-ps1 |
fucosyltransferase 4, pseudogene 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of FUT6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 9:1,569,605...1,572,022
|
|
G |
Fxyd5 |
FXYD domain-containing ion transport regulator 5 |
increases expression |
ISO |
methyleugenol results in increased expression of FXYD5 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:86,267,937...86,277,329
Ensembl chr 1:86,267,406...86,277,519
|
|
G |
Fyb2 |
FYN binding protein 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of FYB2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:119,677,116...119,800,911
Ensembl chr 5:119,677,204...119,800,910
|
|
G |
Fyn |
FYN proto-oncogene, Src family tyrosine kinase |
decreases expression |
ISO |
methyleugenol results in decreased expression of FYN mRNA |
CTD |
PMID:32234424 |
|
NCBI chr20:42,767,733...42,960,903
Ensembl chr20:42,766,369...42,959,911
|
|
G |
G0s2 |
G0/G1switch 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of G0S2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:104,806,351...104,807,263
Ensembl chr13:104,806,156...104,807,451
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of G6PC1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
|
|
G |
Gad1 |
glutamate decarboxylase 1 |
increases expression |
ISO |
methyleugenol results in increased expression of GAD1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:55,369,704...55,410,335
Ensembl chr 3:55,369,704...55,410,333
|
|
G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
increases expression |
ISO |
methyleugenol results in increased expression of GADD45B mRNA |
CTD |
PMID:15618236 |
|
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
|
|
G |
Galnt13 |
polypeptide N-acetylgalactosaminyltransferase 13 |
decreases expression |
ISO |
methyleugenol results in decreased expression of GALNT13 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:38,903,695...39,560,683
Ensembl chr 3:38,974,490...39,558,803
|
|
G |
Galnt16 |
polypeptide N-acetylgalactosaminyltransferase 16 |
decreases expression |
ISO |
methyleugenol results in decreased expression of GALNT16 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:100,168,943...100,250,718
Ensembl chr 6:100,170,306...100,250,705
|
|
G |
Galntl6 |
polypeptide N-acetylgalactosaminyltransferase-like 6 |
decreases expression |
ISO |
methyleugenol results in decreased expression of GALNTL6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:31,192,880...32,443,979
Ensembl chr16:31,186,462...32,441,960
|
|
G |
Gas1 |
growth arrest-specific 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of GAS1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:4,482,168...4,485,153
|
|
G |
Gatm |
glycine amidinotransferase |
decreases expression |
ISO |
methyleugenol results in decreased expression of GATM mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:109,658,919...109,675,508
Ensembl chr 3:109,658,951...109,684,129
|
|
G |
Gba3 |
glucosylceramidase beta 3 |
decreases expression |
ISO |
methyleugenol results in decreased expression of GBA3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:60,574,974...60,721,411
Ensembl chr14:60,574,976...60,721,653
|
|
G |
Gbp7 |
guanylate binding protein 7 |
decreases expression |
ISO |
methyleugenol results in decreased expression of GBP7 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:231,275,521...231,297,289
Ensembl chr 2:231,275,640...231,297,278
|
|
G |
Gc |
GC, vitamin D binding protein |
decreases expression |
ISO |
methyleugenol results in decreased expression of GC mRNA |
CTD |
PMID:32234424 |
|
NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567
|
|
G |
Gcdh |
glutaryl-CoA dehydrogenase |
decreases expression |
ISO |
methyleugenol results in decreased expression of GCDH mRNA |
CTD |
PMID:32234424 |
|
NCBI chr19:23,263,215...23,269,689
Ensembl chr19:23,263,264...23,269,681
|
|
G |
Gcgr |
glucagon receptor |
decreases expression |
ISO |
methyleugenol results in decreased expression of GCGR mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:105,808,474...105,816,641
Ensembl chr10:105,808,473...105,816,640
|
|
G |
Gchfr |
GTP cyclohydrolase I feedback regulator |
decreases expression |
ISO |
methyleugenol results in decreased expression of GCHFR mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:106,158,046...106,162,080
Ensembl chr 3:106,159,394...106,162,080
|
|
G |
Gcnt3 |
glucosaminyl (N-acetyl) transferase 3, mucin type |
increases expression |
ISO |
methyleugenol results in increased expression of GCNT3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:70,689,173...70,696,476
Ensembl chr 8:70,686,844...70,699,562
|
|
G |
Gdf11 |
growth differentiation factor 11 |
increases expression |
ISO |
methyleugenol results in increased expression of GDF11 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:1,311,732...1,325,211
Ensembl chr 7:1,311,732...1,320,725
|
|
G |
Gdf15 |
growth differentiation factor 15 |
increases expression |
ISO |
methyleugenol results in increased expression of GDF15 mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Gdnf |
glial cell derived neurotrophic factor |
increases expression |
ISO |
methyleugenol results in increased expression of GDNF mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:56,894,022...56,919,935
Ensembl chr 2:56,895,010...56,917,209
|
|
G |
Gem |
GTP binding protein overexpressed in skeletal muscle |
increases expression |
ISO |
methyleugenol results in increased expression of GEM mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:25,214,309...25,225,222
Ensembl chr 5:25,214,309...25,225,222
|
|
G |
Gfpt2 |
glutamine-fructose-6-phosphate transaminase 2 |
increases expression |
ISO |
methyleugenol results in increased expression of GFPT2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:34,115,005...34,161,329
Ensembl chr10:34,115,052...34,161,329
|
|
G |
Gfra1 |
GDNF family receptor alpha 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of GFRA1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:257,315,682...257,552,004
Ensembl chr 1:257,321,742...257,551,473
|
|
G |
Ghr |
growth hormone receptor |
decreases expression |
ISO |
methyleugenol results in decreased expression of GHR mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:52,541,452...52,804,960
Ensembl chr 2:52,542,594...52,804,735
|
|
G |
Gipc2 |
GIPC PDZ domain containing family, member 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of GIPC2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:241,030,764...241,110,236
Ensembl chr 2:241,030,770...241,110,236
|
|
G |
Gja3 |
gap junction protein, alpha 3 |
increases expression |
ISO |
methyleugenol results in increased expression of GJA3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:31,181,360...31,206,820
Ensembl chr15:31,181,369...31,206,810
|
|
G |
Gla |
galactosidase, alpha |
increases expression |
ISO |
methyleugenol results in increased expression of GLA mRNA |
CTD |
PMID:32234424 |
|
NCBI chr X:97,769,227...97,780,646
Ensembl chr X:97,768,996...97,780,664
|
|
G |
Gldc |
glycine decarboxylase |
decreases expression |
ISO |
methyleugenol results in decreased expression of GLDC mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:227,883,249...227,962,119
Ensembl chr 1:227,883,249...227,962,097
|
|
G |
Glipr1 |
GLI pathogenesis-related 1 |
increases expression |
ISO |
methyleugenol results in increased expression of GLIPR1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:47,487,342...47,498,974
Ensembl chr 7:47,487,345...47,498,429
|
|
G |
Glipr2 |
GLI pathogenesis-related 2 |
increases expression |
ISO |
methyleugenol results in increased expression of GLIPR2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:58,170,417...58,202,258
Ensembl chr 5:58,170,425...58,202,272
|
|
G |
Glra3 |
glycine receptor, alpha 3 |
decreases expression |
ISO |
methyleugenol results in decreased expression of GLRA3 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:34,199,937...34,848,773
Ensembl chr16:34,204,811...34,848,753
|
|
G |
Gls2 |
glutaminase 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of GLS2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:617,252...633,424
Ensembl chr 7:617,288...633,426
|
|
G |
Gltpd2 |
glycolipid transfer protein domain containing 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of GLTPD2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:55,233,563...55,236,125
Ensembl chr10:55,233,571...55,235,233
|
|
G |
Glud1 |
glutamate dehydrogenase 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of GLUD1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:9,640,312...9,673,961
Ensembl chr16:9,640,312...9,673,957
|
|
G |
Glul |
glutamate-ammonia ligase |
decreases expression |
ISO |
methyleugenol results in decreased expression of GLUL mRNA |
CTD |
PMID:32234424 |
|
NCBI chr13:65,969,053...66,035,121
Ensembl chr13:66,025,630...66,035,108
|
|
G |
Glyat |
glycine-N-acyltransferase |
decreases expression |
ISO |
methyleugenol results in decreased expression of GLYAT mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:209,704,213...209,724,949
Ensembl chr 1:209,704,268...209,724,942
|
|
G |
Glyctk |
glycerate kinase |
decreases expression |
ISO |
methyleugenol results in decreased expression of GLYCTK mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:106,795,461...106,802,675
Ensembl chr 8:106,797,343...106,802,397
|
|
G |
Gmds |
GDP-mannose 4, 6-dehydratase |
decreases expression |
ISO |
methyleugenol results in decreased expression of GMDS mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:32,095,315...32,621,975
Ensembl chr17:32,095,386...32,621,961
|
|
G |
Gng7 |
G protein subunit gamma 7 |
decreases expression |
ISO |
methyleugenol results in decreased expression of GNG7 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:8,697,458...8,761,239
Ensembl chr 7:8,697,521...8,761,240
|
|
G |
Gnmt |
glycine N-methyltransferase |
decreases expression |
ISO |
methyleugenol results in decreased expression of GNMT mRNA |
CTD |
PMID:32234424 PMID:35690182 |
|
NCBI chr 9:14,254,675...14,258,028
Ensembl chr 9:14,254,675...14,258,434
|
|
G |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
decreases expression |
ISO |
methyleugenol results in decreased expression of GPAM mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:254,106,323...254,170,755
Ensembl chr 1:254,106,331...254,142,639
|
|
G |
Gpc2 |
glypican 2 |
increases expression |
ISO |
methyleugenol results in increased expression of GPC2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr12:17,277,875...17,284,297
Ensembl chr12:17,277,875...17,284,208
|
|
G |
Gpc5 |
glypican 5 |
decreases expression |
ISO |
methyleugenol results in decreased expression of GPC5 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:92,207,275...93,644,054
Ensembl chr15:92,239,176...93,643,282
|
|
G |
Gpc6 |
glypican 6 |
decreases expression |
ISO |
methyleugenol results in decreased expression of GPC6 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr15:94,030,218...95,027,883
Ensembl chr15:94,029,884...95,024,006
|
|
G |
Gpd1 |
glycerol-3-phosphate dehydrogenase 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of GPD1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:130,842,526...130,851,530
Ensembl chr 7:130,844,138...130,851,529
|
|
G |
Gphn |
gephyrin |
decreases expression |
ISO |
methyleugenol results in decreased expression of GPHN mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:96,954,365...97,483,617
Ensembl chr 6:96,892,148...97,483,612
|
|
G |
Gpm6a |
glycoprotein m6a |
decreases expression |
ISO |
methyleugenol results in decreased expression of GPM6A mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:36,641,282...36,973,377
Ensembl chr16:36,641,284...36,973,475
|
|
G |
Gpr153 |
G protein-coupled receptor 153 |
decreases expression |
ISO |
methyleugenol results in decreased expression of GPR153 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 5:162,781,587...162,792,975
Ensembl chr 5:162,781,587...162,792,971
|
|
G |
Gpr160 |
G protein-coupled receptor 160 |
decreases expression |
ISO |
methyleugenol results in decreased expression of GPR160 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:112,483,364...112,563,072
Ensembl chr 2:112,484,935...112,563,148
|
|
G |
Gpr87 |
G protein-coupled receptor 87 |
increases expression |
ISO |
methyleugenol results in increased expression of GPR87 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 2:143,439,741...143,440,901
Ensembl chr 2:143,439,735...143,458,190
|
|
G |
Gprc5a |
G protein-coupled receptor, class C, group 5, member A |
increases expression |
ISO |
methyleugenol results in increased expression of GPRC5A mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:167,903,542...167,922,276
Ensembl chr 4:167,903,542...167,922,260
|
|
G |
Gprc5b |
G protein-coupled receptor, class C, group 5, member B |
increases expression |
ISO |
methyleugenol results in increased expression of GPRC5B mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:173,316,904...173,340,933
Ensembl chr 1:173,316,907...173,340,932
|
|
G |
Gprin1 |
G protein-regulated inducer of neurite outgrowth 1 |
increases expression |
ISO |
methyleugenol results in increased expression of GPRIN1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr17:9,863,881...9,876,832
Ensembl chr17:9,863,571...9,876,915
|
|
G |
Gpsm1 |
G-protein signaling modulator 1 |
increases expression |
ISO |
methyleugenol results in increased expression of GPSM1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 3:9,140,816...9,167,828
Ensembl chr 3:9,128,636...9,167,827
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
decreases expression |
ISO |
methyleugenol results in decreased expression of GPT mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Grap |
GRB2-related adaptor protein |
decreases expression |
ISO |
methyleugenol results in decreased expression of GRAP mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:46,298,965...46,352,057
Ensembl chr10:46,332,909...46,352,056
|
|
G |
Greb1 |
growth regulating estrogen receptor binding 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of GREB1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 6:39,440,522...39,562,364
Ensembl chr 6:39,440,504...39,581,633
|
|
G |
Grid1 |
glutamate ionotropic receptor delta type subunit 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of GRID1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr16:10,138,564...10,885,803
Ensembl chr16:10,138,925...10,885,808
|
|
G |
Grid2 |
glutamate ionotropic receptor delta type subunit 2 |
decreases expression |
ISO |
methyleugenol results in decreased expression of GRID2 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 4:92,415,019...93,892,472
Ensembl chr 4:92,415,230...93,889,355
|
|
G |
Grik4 |
glutamate ionotropic receptor kainate type subunit 4 |
decreases expression |
ISO |
methyleugenol results in decreased expression of GRIK4 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 8:42,903,043...43,331,990
Ensembl chr 8:42,905,056...43,193,751
|
|
G |
Grik5 |
glutamate ionotropic receptor kainate type subunit 5 |
decreases expression |
ISO |
methyleugenol results in decreased expression of GRIK5 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 1:80,605,878...80,667,896
Ensembl chr 1:80,605,892...80,667,125
|
|
G |
Grin2c |
glutamate ionotropic receptor NMDA type subunit 2C |
increases expression |
ISO |
methyleugenol results in increased expression of GRIN2C mRNA |
CTD |
PMID:32234424 |
|
NCBI chr10:100,488,430...100,507,083
Ensembl chr10:100,488,431...100,506,427
|
|
G |
Grip1 |
glutamate receptor interacting protein 1 |
decreases expression |
ISO |
methyleugenol results in decreased expression of GRIP1 mRNA |
CTD |
PMID:32234424 |
|
NCBI chr 7:54,934,856...55,592,274
Ensembl chr 7 | |